Patient Information: Articles: Articles for Patients:

Click to download printable and complete CV

Background on Dr. Foster

As this Web Site is being increasingly visited, we increasingly receive requests via e-mail for additional information about the background, education and training of Dr. Foster. And while this site is intended as an educational, noncommercial one, it would appear that a need exists to place at least a "bare bones" Curriculum Vitae under the Patient Information Section of this site regarding Dr. Foster.

Dr. Foster received his Bachelor of Science Degree in Chemistry at Duke University, with Distinction and Phi Beta Kappa in 1965, and received his Doctor of Medicine Degree at Duke University Medical Center, in 1969, being elected to Alpha Omega Alpha. He trained in Internal Medicine at Duke University Hospital from 1969-1970, and at the National Heart and Lung Institute, at the National Institutes of Health in Bethesda, Maryland, from 1970 to 1972, during which time he also taught Internal Medicine, with appointment as Instructor in Medicine at the George Washington University Hospital in Washington, DC. In 1972, Dr. Foster entered his Ophthalmology Residency training program at Washington University (Barnes Hospital), in St. Louis, Missouri, and having completed that in 1975, he then traveled to Boston to do two additional Fellowship trainings in Cornea and External Diseases, and in Ocular Immunology. He completed this training in 1977 and was invited to join the full-time faculty of the Department of Ophthalmology of Harvard Medical School, where he was a member of the Cornea Service and Director of the Residency Training Program at the Massachusetts Eye and Ear Infirmary. He began his independent research in 1977, and was continuously funded by grants from the National Institutes of Health until he chose to focus primarily on Clinical Practice in 1990.

He created the Ocular Immunology and Uveitis Service at the Massachusetts Eye and Ear Infirmary in 1980, and began the Uveitis and Ocular Immunology Fellowship in 1984. Over 100 Ophthalmologists have successfully completed this training program in uveitis and ocular immunology, and most have contributed to the over 500 published books and papers that Dr. Foster has authored. Dr. Foster continues to direct a research laboratory at the Massachusetts Eye Research and Surgery Institution (MERSI), through the support of his newly created research foundation, The Ocular Immunology and Uveitis Foundation; this laboratory is devoted to the study of eye surgery, inflammation, and infections. Dr. Foster sees and treats patients with cataract, glaucoma, cornea and external ocular diseases, and uveitis. He teaches cataract, corneal microsurgery, and vitreal surgery for inflammatory eye disease.

The following is a current copy of Dr. Foster's Curriculum Vitae:

EDUCATION:

1965 Duke University, B.S. Chemistry, with Distinction
9/67 - 6/68 Duke University, Graduate School of Arts & Sciences:
Immunology/Biochemistry
9/65 - 6/69 Duke University School of Medicine, M.D.

POSTDOCTORAL TRAINING:

Internships and Residencies:

7/69 - 6/70 Intern in Medicine
Duke University Medical Center
7/70 - 6/72 Internal Medicine
National Institutes of Health
National Heart & Lung Institute:
Blood, Vasculitis Branch
7/72 - 6/75 Resident in Ophthalmology
Washington University of St. Louis
School of Medicine, Barnes Hospital

RESEARCH FELLOWSHIPS:

7/75 - 6/77 Research Fellow
Department of Cornea Research
Eye Research Institute of Retina Foundation
7/75 - 6/76 Clinical Fellow, Cornea Service
Massachusetts Eye and Ear Infirmary
7/76 - 6/77 Chief Clinical Fellow, Cornea Service
Massachusetts Eye and Ear Infirmary
7/76 - 6/77 Fellow in Ocular Immunology
Harvard Medical School

LICENSURE AND CERTIFICATION:

1969 North Carolina Board of Medical Examiners
1970 National Board of Medical Examiners
1970 Maryland Board of Medical Examiners
1970 District of Columbia Medical Examiners
1972 Missouri Board of Medical Examiners
1975 Massachusetts Board of Medical Examiners
1976 American Board of Ophthalmology, Diplomat
1981 American College of Surgeons
1995 American College of Rheumatology

ACADEMIC APPOINTMENTS:

10/70 - 7/72 Instructor in Medicine, George Washington University Medical Center
7/76 - 6/79 Instructor in Ophthalmology, Harvard Medical School
7/77 - 1/81 Clinical Assistant Scientist, Department of Cornea Research
Director, Immunopathology Laboratory
Eye Research Institute of Retina Foundation
7/79 - 6/82 Assistant Professor of Ophthalmology, Harvard Medical School
1/81 - 1/84 Clinical Associate Scientist, Department of Cornea Research
Eye Research Institute of Retina Foundation
7/82 - 2/94 Associate Professor of Ophthalmology, Harvard Medical School
3/94 - Present Clinical Professor of Ophthalmology, Harvard Medical School

HOSPITAL APPOINTMENTS:

7/76 - 5/81 Director, Residency Training (Ophthalmology)
Massachusetts Eye and Ear Infirmary
7/77 - 5/82 Assistant in Ophthalmology
Massachusetts Eye and Ear Infirmary
5/82 - 7/85 Assistant Surgeon of Ophthalmology
Massachusetts Eye and Ear Infirmary
7/85 - 6/87 Associate Surgeon of Ophthalmology
Massachusetts Eye and Ear Infirmary
7/87 - present Surgeon in Ophthalmology
Massachusetts Eye and Ear Infirmary
6/81 – 3/05 Founder and Director, Ocular Immunology and Uveitis Service
Massachusetts Eye and Ear Infirmary
1/84 – 3/05 Founder and Director, Hilles Immunology Laboratory
Massachusetts Eye and Ear Infirmary
1/88 – 3/05 Founder and Director, Rhoads Molecular Immunology Laboratory
Massachusetts Eye and Ear Infirmary
1/93 - 5/96 Board of Surgeons, Massachusetts Eye and Ear Infirmary
4/94 – 2/05 Executive Committee, Department of Ophthalmology
Harvard Medical School
8/96 - present Clinical Associate in Surgery, Massachusetts General Hospital

VISITING APPOINTMENTS AND SPECIAL LECTURES:

1979 Wills Eye Hospital, Visiting Professor
1979 University of Paris, Visiting Professor
1980 National Eye Institute Task Force: Autoimmune Phenomena and Ocular Disorders
1980 National Eye Institute Task Force: Infection, Inflammation, and Allergy
1980 Moorefield's Eye Hospital, London, Visiting Professor
1980 University of Paris, Visiting Professor
1981 University of Paris, Visiting Professor
1981 National Institutes of Health, Maryland, Ad Hoc Review Study Section
1981 Wills Eye Hospital, Visiting Professor
1982 Washington University of St. Louis, Visiting Professor
1982 University of Paris, Visiting Professor
1982 Brookdale Hospital, New York, Visiting Professor
1982 Georgetown University, Visiting Professor
1982 Eye Research Institute Symposium, Palm Beach, FL, Guest Lecturer
1982 Lenox Hill Hospital New York, Visiting Professor
1982 New York Eye and Ear Infirmary, Visiting Professor
1982 Symposium and Satellite Telecast on "Radial Keratotomy and Extended Wear
Contact Lenses," San Francisco, CA, Guest Speaker
1982 University of Maryland School of Medicine, Advances of Ophthalmology,
Guest Lecturer
1983 Brigham and Women's Hospital, Boston, MA, Guest Lecturer at Grand Rounds
1983 University Hospitals of Cleveland, Guest Lecturer at Grand Rounds of Cleveland
Ophthalmological Society
1983 Fisons Corp. Cromolyn Symposium, Guest Lecturer
1983 St. Luke's-Roosevelt Hospital, New York, Guest Lecturer at Grand Rounds
1983 Southend General Hospital, London, Visiting Professor
1983 University of Paris, Guest Lecturer
1983 National Institutes of Health, Maryland, Visiting Professor
1983 University of South Carolina in Columbia, Guest Lecturer
1984 North Shore University Hospital New York, Guest Lecturer
1984 Manhattan Eye & Ear Institute New York, Visiting Professor
1984 International Corneal Society, Cannes, France, Lecturer
1984 Miami Ophthalmological Society, Visiting Professor
1984 International Symposium on Herpetic Eye Disease, Keynote Speaker
1985 Symposium on Ocular Immunology, Uppsala, Sweden, Keynote Speaker
1985 First International Allergy Symposium, St. Petersburg, FL, Invited Lecturer
1985 University of Michigan, Visiting Professor, Keynote Speaker
1985 First International Allergy Symposium, St. Petersburg, FL, Invited Lecturer
1985 Guest of Honor, Recipient of Hippocrates Medal, Swedish Royal Academy of
Medicine, Stockholm, Sweden
1986 Ocular Immunology Symposium, St. Petersburg, FL, Keynote Speaker
1986 Ocular Allergy Symposium, St. Petersburg, FL, Keynote Speaker
1986 Ocular Immunology, Tubingin, Germany, Invited Lecturer
1986 International Symposium on Herpes Diseases of the Eye, Lake Tahoe, CA,
Invited Lecturer
1986 American Academy of Ophthalmology, Regional Update Course, Washington,
DC, Lecturer
1986 Connecticut Ophthalmological Society, Guest of Honor
1986 American Rheumatism Association, Invited Lecturer
1986 University of Florida, Visiting Professor
1987 Swedish Ophthalmological Society, Guest of Honor
1987 Problem Solving in Corneal Disease, San Juan, Puerto Rico, Invited Lecturer
1987 Cooperation Between the Ophthalmologist and Non-Ophthalmologist, San Juan,
Puerto Rico, Invited Lecturer
1987 New York City Immunology Course, Manhattan Eye, Ear and Throat Hospital,
Invited Lecturer
1987 Arthritis Grand Rounds, Massachusetts General Hospital, Boston, MA,
Invited Lecturer
1987 Department of Allergy, New England Medical Center, Boston, MA,
Invited Lecturer
1987 Corneal Problems Solving Course, Massachusetts Eye & Ear Infirmary,
Boston, MA, Invited Lecturer
1987 Grand Rounds, Sympathetic Ophthalmia, Massachusetts Eye & Ear Infirmary,
Boston, MA, Invited Lecturer
1987 Johns Hopkins University, Visiting Professor
1987 Massachusetts Eye & Ear Infirmary, Alumni Meeting, Boston, MA,
Invited Speaker
1987 Dupont de Nemours and Co., Wilmington, DE, Visiting Professor
1987 New York University, Division of Rheumatology, Visiting Professor
1987 Manhattan Eye, Ear & Throat Hospital, Visiting Professor
1987 World Cornea Conference, Washington, DC, Invited Speaker
1987 American Ophthalmological Society, Carlsbad, CA, Invited Speaker
1987 Canadian Ophthalmological Society, Montreal, Canada, Invited Speaker
1987 World Congress on Sarcoidosis, Milan, Italy, Invited Speaker
1987 Norwegian Ophthalmological Society, Guest of Honor
1988 American Rheumatism Foundation, San Francisco, CA, Invited Speaker
1988 DalHousie University Faculty Title of Medicine, Halifax, Nova Scotia,
Invited Speaker
1988 Lenox Hill Hospital, New York, NY, Invited Speaker
1988 University of Mississippi, Jackson, MS, Invited Speaker
1988 University of Paris, Invited Speaker
1988 Cambridge University, Visiting Professor
1988 New England Ophthalmic Society, Boston, MA, Invited Speaker
1988 American Academy of Ophthalmology, Las Vegas, NV, Visiting Professor
1988 Turkish Ophthalmological Society, Istanbul, Turkey, Invited Speaker
1989 Missouri Ophthalmological Society, Kansas City, MO, Invited Speaker
1989 First Annual Cornea and Anterior Segment Symposium, University of New
Jersey School of Medicine, Visiting Professor
1989 Long Island Jewish-Hillside Medical Center, Grand Rounds, Invited Speaker
1989 University of Michigan, Detroit, MI
1990 Fifth International Symposium on Immunology and Immunopathology of the Eye.
Tokyo, Invited Speaker
1990 Castroviejo Cornea Society, Invited Speaker
1990 International Congress of Ophthalmology, Singapore, Invited Speaker
1990 State University of New York, Dept. of Immunology. Buffalo, NY.
"Immunosuppression and the Role of Cyclosporine in Patient Management,"
Invited Speaker
1990 Manhattan Eye, Ear, & Throat Hospital, Conference on External Eye Disease,
Invited Speaker
1990 International Symposium for Ocular Inflammation. Alicante, Spain,
Invited Speaker
1990 American Academy of Ophthalmology, Regional Update Course, Cambridge, MA
Invited Speaker
1990 First International Symposium on Intermediate Uveitis. Gutersloh, Germany,
Visiting Professor.
1990 Fourth Workshop on External Eye Disease and Inflammation. Bilesly, England.
Invited Speaker.
1990 Second Annual University of Illinois, Eye Center Meeting. Chicago, Illinois.
Ocular Immunology Lecture: Chronic Cicatrizing Conjunctivitis. Invited Speaker.
1990 Massachusetts Eye & Ear Infirmary, Immunology Course. Course Director
1990 Boston University School of Medicine, Resident Lecture Series. Visiting Professor
1990 American Academy of Ophthalmology, Atlanta, GA, Invited Speaker
1990 American Uveitis Society, Course on Uveitis, Atlanta, GA, Instructor
1991 Cullen Memorial Lecture, Ohio State University, Invited Speaker
1991 Manhattan Eye & Ear Hospital, Grand Rounds, Mucous Membrane Disease.
Visiting Professor.
1991 Massachusetts General Hospital, Grand Rounds, Visiting Professor.
1991 Valladolid, Spain. Guest of Honor.
1991 Spaulding Hospital, Immunologic Diseases of the Eye. Visiting Professor.
1991 Manhattan Eye & Ear Hospital, New York, Visiting Professor.
1991 AAO Update. Lecturer.
1991 American Uveitis Society, Course on Uveitis, Instructor
1991 Cornea Day. New England Ophthalmological Society, Boston Park Plaza Hotel,
Fungal Keratitis. Invited Speaker.
1991 University of Maryland, Grand Rounds, Visiting Professor.
1991 Rheumatology Department, SUNY Stoneybrook, Visiting Professor.
1991 Georgetown University, Visiting Professor.
1991 New York City Ophthalmology Course, Ocular Immunology. Visiting Professor.
1992 Long Island Jewish Memorial. Visiting Professor.
1992 Seattle, Washington Academy of Ophthalmology. Featured Speaker.
1992 Tubingen, Germany. Guest of Honor.
1992 Chicago Ophthalmologic Society. Featured Speaker.
1992 New Jersey Conference. Invited Speaker.
1992 Brussels International Conference. IXth Congress of Ophthalmology.
Keynote Speaker.
1992 Stresa, Italy. International Society for Eye Research. Featured Speaker.
1992 Course on Cornea: Current Problems, Paris, France. Invited Lecturer.
1992 American Uveitis Society, Course on Uveitis, Instructor
1992 Visiting Professor, Grand Rounds, University of Pittsburgh.
1992 2nd Inger Sandstrom Memorial Lecture. Swedish Medical Society Meeting,
Stockholm, Sweden.
1993 Visiting Professor, Grand Rounds, McGill University, Montreal.
1993 New Orleans Academy, Featured Speaker
1993 Baltimore, MD, Sinai Hospital, Visiting Professor
1993 American Uveitis Society, Course on Uveitis, Instructor
1993 National Eye Institute, Visiting Professor
1994 Columbia University, Visiting Professor
1994 National Institutes of Health, Visiting Professor
1994 Francisco J. Bajandas Memorial Lecture, University of Texas, San Antonio,
Visiting Professor.
1994 University of Berlin Medical College, Visiting Professor
1994 University of California San Francisco, Visiting Professor
1994 University of Michigan, Visiting Professor
1994 University of Utah, Visiting Professor, Grand Rounds
1994 Joint Allergist/Ophthal. Meeting, Buffalo, NY, Featured Speaker
1994 University of South Florida, Visiting Professor, Grand Rounds
1994 Cooperstown, NY, Anterior Segment Conference, Featured Lecturer
1994 Salt Lake City, UT, VanDyk Memorial Lecture
1994 Rhode Island Society of Eye Physicians, Guest Speaker
1994 WV Kanawha Society of Ophthalmologists, Guest Speaker
1994 SUNY Post-Graduate Review, Syracuse, NY, Featured Speaker
1995 Washington University Medical Center, MO, Visiting Professor
1995 Loyola University, Loyola, IL, Visiting Professor
1995 Colorado Ophthalmological Society, CO, Featured Speaker
1995 Escola Paulista de Medicina, São Paulo, Visiting Professor
1995 Brookdale Ophthalmologic Society, NY, Guest Speaker
1995 National Dutch Ophthal. Congress, Amsterdam, Invited Lecturer
1995 Oregon Academy of Ophthalmology, OR, Guest Speaker
1995 Loma Linda Univ. Post-Graduate Convention, CA, Guest Speaker
1995 Calif. Pacific Medical Center, San Francisco, CA, Visiting Professor
1995 Redwood Empire Ophthalmological Society, CA, Guest Speaker
1995 Stanford University, CA, Visiting Professor
1995 Sacramento Kaiser Meeting, Sacramento, CA, Guest Speaker
1995 Northern Calif. Kaiser Quarterly Educ. Mtg., CA, Guest Speaker
1995 Santa Barbara Ophthalmological Society, CA, Guest Speaker
1995 Case-Western Univ. Grand Rounds, Cleveland, Visiting Professor
1995 Xth Congress European Soc. of Ophthal., Milan, Italy, Invited Speaker
1995 Palm Beach Ophthalmological Society, FL, Guest Speaker
1995 Northeast Pennsylvania Pediatric Allergy Society, PA, Guest Speaker
1995 S. Illinois Univ. Ophthalmology Residency Program, IL, Visiting Professor
1995 Cincinnati Society of Ophthalmology Grand Rounds, Guest Speaker
1995 LSU-Shreveport Lecture Series, LA, Visiting Professor
1995 Geneva: First International Symposium on Ocular Pharmacotherapeutics (Merck Sharp & Dohme)
1995 University of Gotenburg, Sweden. Visiting Professor
1996 University of Connecticut Grand Rounds, Guest Speaker
1996 Pierce County/Madigan Hospital Resident Society Meeting, Guest Speaker
1996 Wake Forest Eye Center Grand Rounds, Guest Speaker
1996 Indianapolis Ophthalmological Society, IN, Guest Speaker
1996 No. Rhode Island Ophthalmological Society, Providence, RI, Guest Speaker
1996 Tidewater Ophthalmology & Otolaryngology, Norfolk, VA, Guest Speaker
1996 World Congress on the Cornea IV, Orlando, FL, Invited Speaker
1996 UCLA/Jules Stein Eye Institute, Los Angeles, CA, Visiting Professor
1996 New York Hospital-Cornell Medical Center Grand Rounds, Invited Speaker
1996 Delaware Ophthalmological Society
1996 St. Louis Ophthalmological Society
1996 Phoenix Ophthalmological Society
1996 University of Arizona, Visiting Professor
1996 Columbia Ophthalmological Society
1996 Philadelphia Ophthalmological Society
1996 Tacoma Ophthalmological Society, Guest of Honor
1996 University of Arkansas, Visiting Professor
1996 University of Paris, Visiting Professor
1996 Workshop on Ocular Autoimmunity in Skin Disease, Ettal, Germany
1996 Brookdale Ophthalmological Society
1996 Dayton Ophthalmological Society
1996 Raleigh Ophthalmological Society
1996 University of Miami, Visiting Professor
1996 Miami Ophthalmological Society
1996 Guest of Honor, University of Gotland (Sweden)
1996 New Jersey Medical School, Visiting Professor
1996 Grand Rounds, Neurology Department, MGH
1996 Alabama Academy of Ophthalmology
1996 South Western Virginia Ophthalmological Society
1996 Akron Ophthalmological Society
1996 Case Western Reserve, Visiting Professor
1996 University of Washington, Visiting Professor
1996 University of Oregon, Visiting Professor
1996 Alta Society, Sacramento, CA, Guest of Honor
1996 Florida Ophthalmological Society
1996 University of Wisconsin, Visiting Professor
1996 University of Missouri, Visiting Professor
1996 University of Rochester, Visiting Professor, Bujones Memorial Lecture
1996 Keynote Address, Second International Symposium on the
Lacrimal Gland, Bermuda
1996 Univeristy of New Mexico, Visiting Professor
1996 Santa Barbara Ophthalmological Society
1996 Phoenix Ophthalmological Society
1996 University of Texas, El Paso, Visiting Professor
1996 Martin Luther King Hospital, Los Angeles, CA, Visiting Professor
1996 Fresno Ophthalmological Society, Invited Speaker
1997 King Khalid Eye Hospital, Riyadh, Saudi Arabia, Visiting Professor
1997 University of Colorado, Visiting Professor
1997 Colorado Ophthalmological Society, Guest of Honor
1997 Allegheny General Hospital (Pittsburgh), Visiting Professor
1997 Wilmer Vail Meeting, Faculty
1997 Dallas Academy of Ophthalmology, Guest of Honor
1997 University of Texas, Southwestern, Visiting Professor
1997 Washington University, St. Louis (Barnes Hospital), Visiting Professor
1997 Rush Presbyterian (Chicago), Visiting Professor
1997 Ostler Course, Faculty
1997 New York Eye and Ear Infirmary, Visiting Professor
1997 European Society of Ophthalmology (Budapest), Course Faculty
1997 New England Ophthalmological Society, Invited Speaker
1997 Pittsburgh Eye and Ear Hospital, Visiting Professor
1997 International Symposium on Ocular Pharmacology (Munich), Organizer
1997 University of Oregon, Visiting Professor
1997 American Academy of Ophthalmology, LEO Course, Instructor
1997 East Bay Ophthalmologic al Society (Oakland), Invited Speaker
1997 Minneapolis Ophthalmological Society, Guest of Honor
1997 American College of Rheumatology, Keynote Speaker
1997 Virginia Society of Ophthalmology, Guest of Honor
1997 Baylor University, Visiting Professor
1997 The Proctor Foundation, Invited Speaker
1997 George Washington University, Visiting Professor
1998 Utah Ophthalmological Society – Guest of Honor
1998 Columbia University, Visiting Professor
1998 Aspen Corneal Society, Invited Speaker
1998 Nassau County Grand Rounds, Invited Speaker
1998 New Orleans Academy of Ophthalmology, Guest of Honor
1998 American Academy of Pediatrics, Pediatric Rheumatology, Keynote Speaker
1998 University of Utah-John Moran Eye Center, Visiting Professor
1998 American Osteopathic Colleges, Annual Meeting, Guest of Honor
1998 XIII Annual International Congress of Eye Research, Paris, France – Section Chairman
1998 Seventh Annual Ocular Surgery News Symposium, New York, NY
1998 Empiric Medical Workshop, Rockville, MD
1998 American Academy of Ophthalmology, LEO Course, Instructor
1998 West Virginia Kanawha Meeting, Invited Speaker
1998 Nassau County Grand Rounds, Guest of Honor
1998 Long Island College Hospital, Visiting Professor
1999 The Conrad Behrens Lecture, CLAO
1999 The Jean Lacerte Lecture, Laval University, Quebec
1999 The Canadian Royal College of Surgeons Lecturer
1999 Aspen Corneal Society – Speaker
1999 Danish Ophthalmological Society, Annual Meeting, Program Director
1999 Barnet Dulaney Eye Foundation
1999 The Robert Coles Lecture, NY Academy of Medicine
1999 Ocular Inflammatory Disease Update, Mexico City
2000 International Symposium on Ocular Pharmacology and Pharmaceutics, Lisbon, Portugal
2000 Barcelona
2000 Swiss Ophthalmological Society, Bern, Switzerland – Guest of Honor
2001 Illinois Association of Ophthalmologists – Invited Speaker
2001 The Harvey Thorpe Lecture – Pittsburgh Ophthalmological Society
2001 Greek Congress of Ophthalmology – Keynote Lecture
2001 Schepens Lecture – Schepens Eye Research Institute
2001 Adamantiades-Behçet's Disease Congress – Keynote Lecture
2002 Pediatric Uveitis Symposium, UCLA – Invited Speaker
2002 The Torrence Makley, Jr. Lecture – Ohio State University
2002 NYC Rheumatology Society – Guest of Honor
2002 Philippine Alumni Meeting, Washington, DC – Invited Speaker
2002 Yale Eye Clinic Symposium – Visiting Professor
2002 Columbia University Rounds – Visiting Professor
2002 Medical Society of New Jersey – Invited Speaker
2002 Opinion Leaders’ Conference, Washington, DC – Invited Speaker – IVIg and the Blistering Dermatoses
2002 Cleveland Clinic – Visiting Professor
2003 Co-originator and organizer of the first Uveitis Subspecialty Day, American Academy of Ophthalmology
2003 La Escuela de Medicina Ignacio A. Santos de la Division Ciencias de la Salud del Insituto Tecnologico y de Estudios Superiores de Monterrey, Monterrey Mexico – Visiting Professor
2003 The Diaz Caneja Lecture, University of Valladolid, Spain
2003 Hospital for Special Surgery, New York City – Grand Rounds, Rheumatology
2004 The Mahlon Barlow Lecture - Johns Hopkins University School of Medicine, Wilmer Eye Institute
2004 University of Medicine and Dentistry of New Jersey – Grand Rounds
2004 International Society of Ocular Pharmacology and Therapuetics – Monaco (Monte Carlo) – Organizer of and Speaker in two sessions
2004 West Virginia University, Visiting Professor
2004 Massachusetts General Hospital Medical Grand Rounds – Speaker
2004 Congress on New Therapies in Retinal Disease, Rome – Invited Speaker
2004 The Kevin Hill Course, Colby College – Speaker
2004 Evidence-based Model for Diagnosis and Therapy of Uveitis, Symposium Director, Massachusetts Eye and Ear Infirmary, Boston
2004 AUS Uveitis Symposium, American Academy of Ophthalmology
2005 Joseph M. Bryan Research Lecture, Duke University, Durham NC
2005 The Richard D. Richards Lectureship, University of Maryland
2005 Brigham and Women’s Hospital, Ocular Allergy, Resident Grand Rounds, Invited Speaker
2005 American Behcet’s Disease Association – Guest of Honor, New York
2005 AAO Uveitis Subspeciality Day – Organizer and Speaker
2005 Massachusetts General Hospital Grand Rounds
2005 Massachusetts General Hospital Dermatology Department Grand Rounds
2005 Massachusetts Eye and Ear Infirmary Resident Lecture Series
2006 Visiting Professor, SUNY, Brooklyn
2006 Visiting Professor, New England Eye Institute
2006 Allergy Conference, Children’s Hospital, Boston
2006 Harvard Course in Allergy & Immunology, Brigham & Women’s Hospital – Invited Speaker
2006 2nd American-European Ophthalmology Symposium, New York
2006 New England Ophthalmological Society – Invited Speaker
2006 Massachusetts Eye and Ear Infirmary Resident Lecture Series
2006 Lancaster Course in Ophthalmology, Lecturer
2006 Visiting Professor, Grand Rounds, University of Texas Health Sciences Center, Houston
2006 Visiting Professor, Grand Rounds, Baylor University, Houston
2006 Houston Ophthalmological Society – Invited Speaker
2006 Guest Speaker, Vermont Optometric Association Annual Meeting
2006 The First Annual Ocular Immunology & Uveitis Foundation Physician Education Conference: What’s New in Anterior Segment Disorders, Syposium Director, Massachusetts Eye Research & Surgery Institute, Cambridge
2006 The Ocular Microbiology Interest Group, American Academy of Ophthalmology, Las Vegas
2006 Visiting Professor, Grand Rounds, University of Rochester
2006 IOIS, Italy
2007 Guest Speaker and Visiting Professor, Long Island Rheumatological Association
2007 The Glover Lisman Lectureship: Manhattan Eye, Ear & Throat Hospital
2007 Visiting Professor, Rheumatology Grand Rounds, Emory University, Atlanta
2007 Lancaster Course in Ophthalmology, Lecturer
2007 The Second Annual Ocular Immunology & Uveitis Foundation Physician Education Conference: What’s New in Posterior Segment Disorders, Syposium Director, Marriot, Cambridge
2007 French American symposium, New York, New York
2007 IOIS, Paris
2008 Lancaster Course in Ophthalmology, Lecturer
2008 Visiting Professor, University of Louisville, Kentucky
2008 KURE, JIA associated Uveitis Conference, Mt Sinai School of Medicine, NY, NY
2008 French American symposium, Boston
2008 The Third Annual Ocular Immunology & Uveitis Foundation Physician Education Conference: What’s New in Anterior Segment Disorders, Syposium Director, Marriot, Cambridge
2008 Ocular Immunology & Uveitis Foundation Physician Education Conference: Birdshot Conference, Syposium Director, Speaker

AWARDS AND HONORS:

1960 Bausch and Lomb Science Prize
1960 National Merit Scholar
1961 Beta Omega Sigma Leadership Honorary
1965 Phi Beta Kappa
1965 Graduation with Highest Distinction in Chemistry
1965 Chemistry Prize
1969 Alpha Omega Alpha
1979 Sigma XI
1985 Hippocrates Medal, Swedish Royal Academy of Medicine
1986 American Ophthalmological Society
1994 The Best Doctors in America: Town and Country Magazine
1995 Research to Prevent Blindness Senior Scientific Investigator Award
1996 The Best Doctors in America: American Health Magazine
1996 The Best Doctors in America: Ophthalmology Times
2000 America’s Top Doctors: Castle Connolly Medical Ltd.
2001 America’s Top Doctors: Castle Connolly Medical Ltd.
2002 America’s Top Doctors: Castle Connolly Medial Ltd.
2002 Kingston’s National Registry of Who’s Who – Life Member
2002 America’s Registry of Outstanding Professionals
2002 The Best Doctors in America
2003 America’s Top Doctors: Castle Connolly Medical Ltd.
2003 The Diaz Caneja Medal
2003 The International Ocular Inflammation Society Award
2004 America’s Top Doctors: Castle Connolly Medical Ltd.
2004 America’s Top Ophthalmologists: Consumer Research Council of America
2005 Mildred Weisenfeld Award for Outstanding Performance: ARVO
2005 Top Doctors: Boston Herald
2005 America’s Top Doctors: Castle Connolly Medical Ltd.
2005 The Marquis Who’s Who Publication Board
2005 America’s Top Ophthalmologists: Consumer Research Council of America
2006 America’s Top Doctors: Castle Connolly Medical Ltd.
2006 The Best Doctors in America
2006 America’s Top Ophthalmologists: Consumer Research Council of America
2007 American Academy of Ophthalmology Life Achievement Award
2007 America’s Top Doctors: Castle Connolly Medical Ltd.
2007 The Best Doctors in America
2007 America’s Top Ophthalmologists: Consumer Research Council of America
2008 America’s Top Doctors: Castle Connolly Medical Ltd.
2008 The Best Doctors in America
2008 Top Doctors: Boston Magazine
2008 America’s Top Ophthalmologists: Consumer Research Council of America

MAJOR COMMITTEE ASSIGNMENTS:

International
1999 - present International Society of Ocular Pharmacology and Pharmaceutics – Organizing Executive Committee
1999 - present International Ocular Inflammation Society – Executive International Council
2003 - present International Uveitis Study Group

National
1980 American Academy of Ophthalmology - Continuing Education Committee, Subcommittee of Planning in Continuing Education in Ophthalmology
1983 - present Corneal Dystrophy Society
1989 - present American Behçet's Disease Association
1991 - present Board of Directors, Castroviejo Cornea Society
1992 - present American Uveitis Society, Executive Committee
1994 Ad Hoc Grant Application Reviewer, National Eye Institute
1994 - 1997 American Uveitis Society, Director, AUS Course on Uveitis, American Academy of Ophthalmology
1994 – present American Uveitis Society, Executive Committee
1998 - present American Uveitis Society, Chairman, Committee on Investments
1999 – present American Uveitis Society, Director, Scientific Meeting
1999 – 2000 American Uveitis Society, Subcommittee on Immunomodulatory Therapy for Ocular Inflammtory Diseases
2000 – present Medical Advisory Board, Stevens-Johnson Syndrome Foundation
2003 – Present American Academy of Ophthalmology- Director- Uveitis Subspecialty Day
2004 – 2008 American Academy of Ophthalmology, Basic and Clinical Science Course – Faculty

Local
1975 – 1981 Teaching Committee, Massachusetts Eye and Ear Infirmary
1975 – 1981 Resident Selection Committee, Massachusetts Eye and Ear Infirmary
1981 – 1987 Infection Control Committee, Massachusetts Eye and Ear Infirmary
1983 – 1987 Pharmacy Committee, Massachusetts Eye and Ear Infirmary
1985 – 2005 Patent Committee, Massachusetts Eye and Ear Infirmary
1985 – 1987 Ambulatory Services Reorganization Task Force,
Massachusetts Eye and Ear Infirmary
1985 – 1987 Marketing Task Force, Massachusetts Eye and Ear Infirmary
1986 – 1988 Overhead Task Force, Massachusetts Eye and Ear Infirmary
1993 – 1996 Board of Surgeons, Massachusetts Eye and Ear Infirmary
1994 – 2005 Executive Committee, Department of Ophthalmology
Massachusetts Eye and Ear Infirmary
2005 – Present Ocular Immunology and Uveitis Foundation – Director- Annual Physician Education Conference
2006-Present Ocular Immunology and Uveitis Foundation, President of the Board of Trustees
2006-Present Ocular Immunology and Uveitis Foundation, Board Development Committee

EDITORIAL BOARDS:

Editorial Board, CME Series of Ophthalmology
Editorial Board, Cornea
Editorial Board, Herpes
Editorial Board, Digital Journal of Ophthalmology (DJO)
Editor-in-Chief, Contemporary Ophthalmology
Editor-in-Chief, Massachusetts Eye Research & Surgery Institute, World Wide Web Site
Editor-in-Chief, www.uveitis.org World Wide Web Site
Editorial Board, Ocular Immunology and Inflammation

EDITORIAL BOARDS, AD HOC REVIEW:

American Journal of Ophthalmology
Archives of Ophthalmology
Ophthalmology
Investigative Ophthalmology
Current Eye Research
Experimental Eye Research
Survey of Ophthalmology
New England Journal of Medicine
Journal of Immunology
Survey of Immunology

MEMBERSHIPS, OFFICES, AND COMMITTEE ASSIGNMENTS IN
PROFESSIONAL SOCIETIES:

General Medicine:
American Medical Association
Massachusetts Medical Society
Royal Society of Medicine, London
Lupus Foundation of America, Inc.
American Behçet’s Disease Association
American College of Rheumatology, Fellow
American College of Surgeons, Fellow

Clinical Ophthalmology:
American Academy of Ophthalmology, Fellow
American Association of Ophthalmology
Massachusetts Society of Eye Physicians & Surgeons
New England Ophthalmological Society
Contact Lens Society of America

Immunology Research:
Ocular Microbiology and Immunology Group
American Association of Immunology
American Society of Ophthalmologic and
Otolaryngologic Allergy
American Uveitis Society, Board of Directors
American Federation for Clinical Research
Federation of American Societies for
Experimental Biology
International Society of Immunopharmacology
American Society for Microbiology
Association of Medical Laboratory Immunologists
American Society of Clinical Immunologists
International Uveitis Study Group
International Ocular Inflammation Society

Ophthalmic Research:
Association for Research in Vision & Ophthalmology
Association for Eye Research – Amsterdam
International Society for Eye Research

MAJOR RESEARCH INTERESTS:

1. General and Ocular Immunology
- Autoimmune Ocular Disease
- Corneal Transplantation Immunology
- Immune Response to Ocular Herpes Simplex Infection
- Immunomodulatory Therapy

2. Ocular Microbiology
- Bacterial, Fungal and Viral Ocular Infections
- Ocular Penetration of Antibiotics

3. Corneal Wound Healing
4. Surgical Therapy of Ocular Inflammatory Disease

TEACHING EXPERIENCE:

Current Annual Teaching Activities:

Resident Lecture Series, Massachusetts Eye and Ear Infirmary

Lancaster Course in Ophthalmology

American Academy of Ophthalmology
Course on: Uveitis
Course on: Scleritis
Course on: Peripheral Corneal Disease
Course on: Chronic Conjunctivitis
Course on: Cornea

Ocular Immunology and Uveitis Foundation Annual Physicain Education Conference
Anterior Segment, 2006, 2008
International Symposium on Birdshot Choroidopathy, 2008
Posterior Segment Conference, 2007

Harvard Medical School, Department of Allergy and Immunology, Annual Fellows’ Course

CONSULTANT POSITIONS:

Consultant, Baxter Laboratories, Travenol Div.
Design and Conduct of Clinical Trials: 1972-1974

Consultant, Fisons Corporations
Design and Conduct of Clinical Trials: 1985-1995

Consultant, Sandoz Pharmaceuticals
Design and Conduct of Clinical Trials: 1990

Consultant, Alcon Pharmaceuticals
Design and Conduct of Clinical Trials: 1990-1995
Basic Research on Inflammation
Speakers’ Bureau

Consultant, Centocor Pharmaceuticals
Immunomodulatory Therapy: 2003 – present

Consultant, Inspire Pharmaceuticals
Clinical Research on Uveitic Macular Edema 2004 – present
Speakers’ Bureau

Consultant, Inotek 2003-present

Consultant, Bausch & Lomb 1997- present
Speakers’ Bureau

Consultant, Genetech 2004-present

Consultant, Sirion 2006-present

Consultant, Therakine 2006-present

Consultant, Allergan 2005-present
Sponsores Research
Speakers’ Bureau

Consultant, EyeGate 2005-present

Consultant, Novartis
Sponsored Research 2007-Present

Consultant, Merrimack 2006-Present

PRINCIPAL CLINICAL AND HOSPITAL SERVICE RESPONSIBILITIES:

Director – Ocular Immunology and Uveitis Service
Massachusetts Eye and Ear Infirmary
Director – Hilles Immunology Laboratory
Massachusetts Eye and Ear Infirmary
Director – Rhodes Molecular Immunology Laboratory
Massachusetts Eye and Ear Infirmary
(Ended in 2005 with the establishment of the Massachusetts Eye Research & Surgery Institute)
Founder & President - Massachusetts Eye Research & Surgery Institution
President & CEO – Ocular Immunology & Uveitis Foundation

GRANTS RECEIVED:

1966 NSF Summer Research Fellowship
1973 Southern Medical Association Fellowship
1975 & 1976 NIH Research Fellowship
1979 NIH (National Eye Institute) R01 Grant EY-03063,01, “Immunopathology of an
Animal Model of Peripheral Ulcerative Keratitis.”
1981 Milton Fund, Harvard University “Autoimmune Corneal Disease”
1982 NIH (National Eye Institute) R01 Grant EY-04092-01 “Regulation of Immune
Responses in the Eye.”In collaboration with Mark I. Greene, M.D., Dept. of
Pathology, Harvard Medical School
1982 NIH R01 Grant CA20822 “Cell Interaction and the Clotting System.”In
conjunction with Robert B. Colvin, M.D., Immunopathology Dept., Mass.
General Hospital
1983 Fight for Sight: “Ocular Immune Responses”
1985 NIH “Immunology and Genetics of Herpes Simplex Keratitis.”
Grant RO1-EY-06008-01
1985 NIH Institutional Training Grant,
Massachusetts Eye and Ear Infirmary
1985 NIH “Case Control Study of Selective Eye Disorders: Uveitis.” In conjunction
with Dr. Johanna Seddon, Massachusetts Eye and Ear Infirmary
1987 NIH R01CA-20822 “Cell Interaction and the Clotting System.” In collaboration
with Robert Colvin, M.D., Mass. Gen. Hospital
1988 NIH T32-EY07097-02 “Multidisciplinary Training in Ophthalmic Science.”
Massachusetts Eye and Ear Infirmary
1989 & 1994 NIH EY08379-01 “Ocular Pemphigoid Mechanism of Pathogenesis.” In
conjunction with A. Razzaque Ahmed, M.D., Center for Blood Research
1989 & 1996 NIH R01 EY06008 “Molecular Genetics of Herpes Simplex-mediated Ocular
Pathology” Massachusetts Eye and Ear Infirmary
1998 NIH EY08379-04 “Ocular Cicatricial Pemphigoid: Mechanism of Pathogenesis.
with A. Razzaque Ahmed, MD, Center for Blood Research
2001 Bausch & Lomb Fluocinolone Implant Study Grant
2005 Inspire Pharmaceuticals Denufosol Uveitic Macular Edema Study Grant
2005 NIH EY 014655-02 “Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study” (SITE)
2006 NIH Multi-Centre Uveitis Steroid Treatment Trial (MUST)
2006 Allergan Posurdex for Intermediate Uveitis
2007 Lux Biosciences Studies on LX 211 (x3)
2007 Merrimack Pharmaceuticals Study Grant
2007 Lux Biosciences Studies on PK
2007 Merrimack Pharmaceuticals: Alphafetoprotein Therapy for Uveitis
2008 Cerimon Pharmaceuticals: Basilixumab Therapy for Uveitis
2008 Sirion Therapeutics: Difluprednate Therapy for Uveitis
2008 Novartis Phamaceuticals: Anti-IL-17 Antibody Therapy for Uveitis
2008 Eyegate Pharma: Iontophoresis of Dexamethasone Therapy for Uveitis
2008 ISTA Phamaceuticals: Bromfenae Therapy for Uveitis
2008 Novartis Phamaceuticals: AEB071 as a therapy for Uveitis in patients with Macular Edema
2008 Novartis Phamaceuticals: RKI983 as a therapy for Uveitis in patients with Glaucoma

BIBLIOGRAPHY: See Publications Section for abstract link

TOP

Original Reports

In Print

1. Waltman SR, Buerk K, Foster CS. Effects of Ophthalmic Ointment on Intraocular Penetration of Topical Fluorescein in Rabbits and Man. Am J Ophthalmol 1974;78:262-4.

2. Foster CS, Brennan L. The Oculocardiac and the Oculorespiratory Reflex. Am Assoc Nurse Anesthetists J 1974;42:317-22.

3. Bohigian GM, Foster CS. Treatment of Pseudomonas keratitis in the rabbit with antibiotic-steroid combinations. Invest Ophthalmol Vis Sci 1977;16:553-556.

4. Foster C, Pavan-Langston D. Corneal Wound Healing and Antiviral Medication. Arch Ophthalmol 1977;95:2062-7.

5. Pavan-Langston D, Foster CS. Trifluorothymidine and Idoxuridine Therapy of Ocular Herpes. Am J Ophthalmol 1977;84:818-25.

6. Mobilia EF, Foster CS. The Management of Recurrent Corneal Erosions with Ultra-Thin Lenses. Cont Intraoc Lens Med J 1978;4:25-9.

7. Donshik PC, Collin HB, Foster CS, Cavanagh HD, Boruchoff SA, Magee AJ. Conjunctival Resection Treatment and Ultrastructural Histopathology of Superior Limbic Keratoconjunctivitis. Am J Ophthalmol 1978;85:101-10.

8. Cannon DJ, Foster CS. Collagen crosslinking in keratoconus. Invest Ophthalmol Vis Sci 1978;17:63-5.

9. Collin HB, Donshik PC, Boruchoff SA, Foster CS, Cavanagh HD. The Fine Structure of Nuclear Changes in Superior Limbic Keratoconjunctivitis. Invest Ophthalmol Vis Sci 1978;17:79-84.

10. Foster CS, Goetzl EJ. Ascorbate Therapy in Impaired Neutrophil and Monocyte Chemotaxis With Atopy, Hyperimmunoglobulinemia E, and Recurrent Infection. Arch Ophthalmol 1978;96:2069-72.

11. Kenyon KR, Foster CS. Thermal Denaturation of Donor Cornea: An Unusual Complication of Penetrating Keratoplasty. Ophth Surg 1978;9:47-51.

12. Collin HB, Donshik PC, Foster CS, Boruchoff SA, Cavanaugh HD. Keratinization of the Bulbar Conjunctival Epithelium in Superior Limbic Keratoconjunctivitis in Humans. Acta Ophthalmol 1978;56:531-43.

13. Foster CS, Yamamoto GK. Ocular Rigidity in Keratoconus. Am J Ophthalmol. 1978;86:802-6.

14. Foster CS, Allansmith MR. Chronic Unilateral Blepharoconjunctivitis Caused by Sebaceous Carcinoma. Am J Ophthalmol 1978;86:218-20.

15. Foster CS, Kenyon KR, Greiner J, Greineder DK, Friedland B, Allansmith MR. The Immunopathology of Mooren’s Ulcer. Am J Ophthalmol 1979;88:149-59.

16. Foster CS, Allansmith MR. Lack of Blood Group Antigen A on Human Corneal Endothelium. Am J Ophthalmol 1979;87:165-70.

17. Mobilia EF, Foster CS. A One-Year Trial of Polycon Lenses in the Correction of Keratoconus. Cont Intraoc Lens Med J 1979;5:37-42.

18. Lamberts DW, Foster CS, Perry HD. Schirmer Test After Topical Anesthesia and the Tear Meniscus Height in Normal Eyes. Arch Ophthalmol 1979;97:1082-5.

19. Foster CS, English J. Coping with Blindness: The Importance of the Ophthalmologist in Referral. J Vis Impair Blind 1979:193-6.

20. Foster CS, Stefanyszyn M. Intraocular Penetration of Miconazole in Rabbits. Arch Ophthalmol 1979;97:1703-6.

21. Lamberts DW, Foster CS. Chronic Unilateral External Ocular Inflammation. Surv Ophthalmol 1979;24:157-66.

22. Foster CS. Ocular Surface Manifestations of Neurological and Systemic Disease. Int Ophthalmol Clin 1979;19:207-42.

23. Foster CS. Vernal Keratoconjunctivitis. Perspectives Ophthalmol 1980;1:35-8.

24. Fogle JA, Kenyon KR, Foster CS. Tissue Adhesive Arrests Stromal Melting in the Human Cornea. Am J Ophthalmol 1980;89:795-802.

25. Foster CS. Immunosuppressive Therapy for External Ocular Inflammatory Disease. Ophthalmology 1980;87:140-9.

26. Foster CS, Duncan J. Randomized Clinical Trial of Topically Administered Cromolyn Sodium for Vernal Keratoconjunctivitis. Am J Ophthalmol 1980;90:175-81.

27. Eliason J, Foster CS. Insect Contamination of a Cornea Stored in M-K Medium. Ophthalmol Surg 1980;11:611-3.

28. Foster CS, Lass JH, Moran-Wallace K, Giovanoni R. Ocular Toxicity of Topical Antifungal Agents. Arch Ophthalmol 1981;99:1081-4.

29. Lass JH, Campbell RC, Rose J, Foster CS, Dohlman CH. Medroxyprogesterone on Corneal Ulceration: Its Effects After Alkali Burns on Rabbits. Arch Ophthalmol 1981;99:673-6.

30. Lass JH, Haaf J, Foster CS, Belcher C. Visual Outcome in Eight Cases of Serratia Marcescens Keratitis. Am J Ophthalmol 1981;92:384-90.

31. Foster CS, Dubey DP, Stux S, Yunis E. Natural Killer (NK) Cytotoxicity and HLA-A, -B, -C, and DR Profile in a Group of Patients with Recurrent Versus Non-recurrent Herpes Simplex Keratitis (HSK). The Cornea in Health and Disease. (VIth Congress of the European Society of Ophthalmology). Royal Society of Medicine International Congress and Symposium 1981;49:733-737.

32. Foster CS, Lass J. Antifungal Ocular Toxicity. The Cornea in Health and Disease. (Vith Congress of the European Society of Ophthalmology). Royal Society of Medicine International Congress and Symposium 1981;40:671-675.

33. Foster CS, Duncan J. Prognostic Factors in Penetrating Keratoplasty for Herpes Simplex Keratitis. The Cornea in Health and Disease. (Vith Congress of the European Society of Ophthalmology). Royal Society of Medicine International Congress and Symposium 1981;40:797-800.

34. Foster CS, Dubey DP, Stux S, Yunis E.. Natural Killer Activity and HLA Phenotypes in Patients with Herpes Simplex Keratitis. Herpetische Augenerkrankungen Munich 1981;85-9.

35. Foster CS. Immunosuppressive Therapy for Experimental Corneal Ulceration. Immunology of the Eye: Workshop II. Autoimmune Phenomena and Ocular disorders. Special Supplement Immunology Abstracts, 1981;91-102.

36. Foster CS, Duncan J. Penetrating Keratoplasty for Herpes Simplex Keratitis. Am J.Ophthalmol 1981;92:336-43.

37. Foster CS. Miconazole Therapy for Keratomycosis. Am J Ophthalmol 1981;91:622-9.

38. Fujikawa LS, Foster CS, Harrist TJ, Lanigan JM, Colvin RB. Fibronectin in Healing Rabbit Corneal Wounds. Lab Invest 1981;45:120-9.

39. Nash IS, Greene PR, Foster CS. Comparison of Mechanical Properties of Keratoconus and Normal Corneas. Exp Eye Res 1982;35:413-24.

40. Mobilia EF, Foster CS. A Comparison of Various Extended Wear Lenses for Use in Aphakia. Contact Intraoc Lens Med J 1982;8:12-5.

41. Foster CS, Zelt RP, Phan T-MM, Kenyon KR. Immunosuppressive and Selective Inflammatory Cell Depletion: Studies on a Guinea Pig Model of Corneal Ulceration After Ocular Alkali Burning. Arch Ophthalmol 1982;100:1820-4.

42. Bhan AK, Fujikawa LS, Foster CS. T-cell Subsets and Langerhans Cells in Normal and Diseased Conjunctiva. Am J Ophthalmol 1982;94:205-12.

43. Foster CS, Wetzig RP, Greene MI. Ocular Immune Responses I. Priming of A/J Mice in the Anterior Chamber with Azobenzenearsonate-Derivatized Cells Induces Second- order-like Suppressor T Cells. J Immunol 1982;128:1753-7.

44. Fujikawa LS, Colvin RB, Bhan AK, Fuller TC, Foster CS. Expression of HLA-A/B/C and –DR Locus Antigens on Epithelial, Stromal, and Endothelial Cells of the Human Cornea. Cornea 1982;1:213-22.

45. Foster CS, Wilson LA, Ekins MB. Immunosuppressive Therapy for Progressive Ocular Cicatricial Pemphigoid. Ophthalmology 1982;89:340-53.

46. Foster CS, Wetzig R. Immune Reactions in the Eye. Surv Immunol Res 1982;1:93-108.

47. Tolentino FI, Foster CS, Lahav M, Luke HS, Liu LHS, Rabin AR. Toxicity of Intravitreous Miconazole. Arch Ophthalmol 1982;100:1504-9.

48. Puliafito CA, Baker AS, Haaf J, Foster CS. Infectious endothalmitis: Review of 36 cases. Ophthalmol 1982;89:921-9.

49. Foster CS. Diagnosis and Therapy of Central Corneal Ulcers I. Differential Diagnosis and Diagnostic Procedures. NY Eye Ear Inf J 1982;3:16-9.

50. Foster CS. Diagnosis and Therapy of Central Corneal Ulcers II: Initial Therapy: Bacterial and Fungal Keratitis. NY Eye Ear Inf J 1982;3:20-4.

51. Foster CS. Immunomodulation in Ophthalmology. Int Ophthalmol Clin 1983;23:183-196.

52. Foster CS, Yee M. Corneoscleral Manifestations of Graves’ Disease and the Acquired Connective Tissue Disorders and Systemic Vasculitis. Int Ophthalmol Clin 1983;23:131-57.

53. Cintron C, Fujikawa LS, Covington H, Foster CS, Colvin RB. Fibronectin in Developing Rabbit Cornea. Curr Eye Res 1983;3:489-99.

54. Foster CS. Herpes Simplex Keratitis. Clinical Ophthalmology Update. 1983;1:2-8.

55. Foster CS. Herpes Zoster Ophthalmicus. Clinical Ophthalmology Update. 1983;1:2-6.

56. Foster CS. Cicatricial Pemphigoid. Clinical Ophthalmology Update. 1983;1:2-6.

57. Tuberville AW, Foster CS, Wood TO. The Effect of Donor Corneal Epithelium Removal on the Incidence of Allograft Rejection Reactions. Ophthalmology 1983;90:1351-6.

58. Foster CS, Forstot SL, Wilson LA. Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis: Effects of systemic immunosuppression. Ophthalmology 1984;91:1253-63.

59. Thoft RA, Friend J, Kinoshita S, Nikoli L, Foster CS. Ocular Cicatricial Pemphigoid Associated with Hyperproliferation of the Conjunctival Epithelium. Am J Ophthalmol 1984;98:37-42.

60. Lass JH, Langston RHS, Foster CS, Pavan-Langston D. Antiviral Medications and Corneal Wound Healing. Antiviral Res 1984;4:143-57.

61. Foster CS. Review of uveitis book by Smith and Nozik. New Engl J Med 1984;310:1063.

62. Fujikawa LS, Foster CS, Gipson IK, Colvin RB. Basement Membrane Components in Healing Rabbit Corneal Epithelial Wounds: Immunofluorescence and Ultrastructural Studies. J Cell Biol 1984;98:128-38.

63. Borodic GE, Beyer-Machule CK, Millin J, Conte J, Foster CS. Immunoglobulin deposition in localized conjunctival amyloidosis. Am J Ophthalmol 1984;98:617-622.

64. Phan T-MM, Zelt RP, Kenyon KR, Chakrabarti B, Foster CS. Ascorbic Acid Therapy in a Thermal Burn Model of Corneal Ulceration in Rabbits. Am J Ophthalmol 1985;99:74-82.

65. Wasson P, Foster CS. Autoimmune Reactions in the Eye. Concepts Immunopathol 1985;2:249-67.

66. Galbavy EJ, Foster CS. Ultrastructural Characteristics of Conjunctiva in Cicatricial Pemphigoid. Cornea 1985;4:127-36.

67. Foster CS, Monroe JG, Campbell R, Kalpaxis J, Wetzig R, Greene MI. Ocular Immune Responses II. Priming of A/J mice in the Vitreous Induces Either Enhancement of or Suppression of Subsequent Hapten-Specific DTH Responses. J Immunol 1985;136:2787-91.

68. Foster CS. Systemic Immunosuppressive Therapy for Progressive Bilateral Mooren’s Ulcer. Ophthalmology 1985;92:1436-9.

69. Pouliquen Y, Patey A, Foster CS, Goichot L, Savoldelli M. Drug-induced Cicatricial Pemphigoid Affecting the Conjunctiva. Ophthalmology 1986;93:775-83.

70. Foster CS, Tsai Y, Monroe JG, Campbell R, Cestari M, Wetzig R, Knipe D, Greene MI. Genetic Studies on Murine Susceptibility to Herpes Simplex Keratitis. Clin Immunol Immunopathol 1986;40:313-25.

71. Sandstrom IK, Foster CS, Wells PA, Knipe D, Caron L, Greene MI. Previous Immunization of Mice with Herpes Simplex Virus Type-1 (HSV-1) Strain MP Protects Against Secondary Corneal Infection. Clin Immunol Immunopathol 1986;40:326-34.

72. Regan CDJ, Foster CS. Retinal Vascular Diseases: Clinical Presentation and Diagnosis. Int Ophthalmol Clin 1986;26:25-53.

73. Foster CS, Regan CDJ. Retinal Vascular Diseases: Management. Int Ophthalmol Clin 1986;26:55-71.

74. Singh G, Guthoff R, Foster CS. Observations on Long-Term Follow-up of Posterior Scleritis. Am J Ophthalmol 1986;101:570-5.

75. Wells PA, Ashur ML, Foster CS. SDS-Gradient Polyacrylamide Gel Electrophoresis of Individual Ocular Mucus Samples from Patients with Normal and Diseased Conjunctiva. Curr Eye Res 1986;5:823-31.

76. Foster CS, Shaw CD, Wells PA. Scanning Electron Microscopy of Conjunctival Surfaces in Patients with Ocular Cicatricial Pemphigoid. Am J Ophthalmol 1986;102:584-91.

77. Wagoner MD, Kenyon KR, Foster CS. Management Strategies in Peripheral Ulcerative Keratitis. Int Ophthalmol Clin 1986;26:147-57.

78. Millin JA, Golub BM, Foster CS. Human Basement Membrane Components of Keratoconus and Normal Corneas. Invest Ophthalmol Vis Sci 1986;27:604-7.

79. Foster CS. Cicatricial Pemphigoid. Thesis for the American Ophthalmological Society. Trans Am Ophthalmol Soc 1986;84:527-663.

80. Morgan CM, Foster CS, D’Amico DJ, Gragoudas ES. Retinal Vasculitis in Polyarteritis Nodosa. Retina 1986;6:205-9.

81. Foster CS. Basic Research and Clinical Aspects of Pseudomonas aeruginosa. Eye and Immunity 1987;39:77-82.

82. Singh G, Foster CS. Epidermal Growth Factor in Alkali-Burned Corneal Epithelial Wound Healing. Am J Ophthalmol 1987;103:802-7.

83. Foster CS, Opremcak EM, Rice B, Wells P, Chung H, Thompson P, Fong LP, Raizman M. Clinical, Pathologic, and Immunopathologic Characteristics of Experimental Murine Herpes Simplex Virus Stromal Keratitis and Uveitis is Controlled by Gene Products from the Igh-1 Locus on Chromosome 12. Trans Am Ophthalmol Soc 1987;85:293-311.

84. Lass JH, Foster CS, Grove AS, Rubenfeld M, Lusk RP, Jenson AB, Lancaster WD. Interferon-Alpha Therapy of Recurrent Conjunctival Papillomas. Am J Ophthalmol 1987;103:294-301.

85. Phan T-MM, Foster CS, Boruchoff SA, Zagachin LM, Colvin RB. Topical Fibronectin in the Treatment of Persistent Corneal Epithelial Defects and Trophic Ulcers. Am J Ophthalmol 1987;104:494-501.

86. Foster CS. Ocular Immunology. Semin Ophthalmol 1988;3:211-20.

87. Opremcak EM, Wells PA, Thompson P, Daigle JA, Rice BA, Millin JA, Foster CS. Immunogenetic Influence of Igh-1 Phenotype on Experimental Herpes Simplex Virus Type-1 Corneal Infection. Invest Ophthalmol Vis Sci 1988;29:749-54.

88. Millin JA, Opremcak EM, Wells PA, Foster CS. Ganglionic Permissivity to HSV-1 Replication and Acyclovir-Induced Latency: An In Vitro Model. Invest Ophthalmol Vis Sci 1988;29:232-8.

89. Foster CS, Fong LP, Azar D, Kenyon KR. Episodic Conjunctival Inflammation after Stevens-Johnson Syndrome. Ophthalmology 1988;95:453-62.

90. Ormerod LD, Foster CS, Paton BG, Haaf J, Baker AS. Ocular Capnocytophaga Infection in an Edentulous, Immunocompetent Host. Cornea 1988;7:218-22.

91. Foster CS. Vitrectomy in the Management of Uveitis. Ophthalmology 1988;95:1011-2.

92. Singh G, Foster CS. 1988. Treatment of Nonhealing Corneal Ulcers and Recurrent Corneal Erosions. The Cornea: Transactions of the World Congress on the Cornea III, (Ed. Cavanagh HD) Raven Press, NY. pp. 45-53.

93. Foster CS, Opremcak EM, Rice B, Wells P, Chung H, Thompson P, Fong LP, Raizman M. Immunogenic Control of Ocular Responses to Herpes Simplex Virus. The Cornea: Transactions of the World Congress on the Cornea III 1988;413-420.

94. Wells PA, DeSiena-Shaw C, Rice B, Foster CS. Detection of ocular mucus in normal human conjunctiva and conjunctiva from patients with cicatricial pemphigoid Using Lectin Probes and Histochemical Techniques. Exp Eye Res 1988;46:485-97.

95. Ormerod LD, Fong LP, Foster CS. Corneal infection in mucosal scarring disorders and Sjögren’s syndrome. Am J Ophthalmol 1988;105:512-8.

96. Singh G, Wilson MR, Foster CS. Mitomycin eye drops as treatment for pterygium. Ophthalmology 1988;95:813821.

97. Foster CS. Ocular manifestations of sarcoidosis preceding systemic manifestations. Sarcoidosis and other granulomatous disorders. Excerpta Medica 1988;756:177-181.

98. Thompson P, Wells PA, Sandstrom IK, Opremcak EM, Millin JA, Daigle JA, Foster CS. Immunomodulation of experimental murine herpes simplex keratitis: I. UV-HSV protection. Curr Eye Res 1988;7:1043-9.

99. Foster CS, Sandstrom IK, Wells PA, Thompson P, Daigle J, Opremcak EM. Immunomodulation of experimental murine herpes simplex keratitis: II. Glycoprotein D protection. Curr Eye Res 1988;7:1051-61.

100. Fong LP, Ormerod DL, Kenyon KR, Foster CS. Microbial keratitis complicating penetrating keratoplasty. Ophthalmology 1988;95:1269-75.

101. Foster CS. Evaluation of topical cromolyn sodium in the treatment of vernal keratoconjunctivitis. Ophthalmology 1988;95:194-201.

102. Raizman MB, Foster CS. Passive transfer of anti-HSV-1 IgG protects against stromal keratitis in mice. Curr Eye Res 1988;7:823-9.

103. Sainz de la Maza M, Tauber J, Foster CS. Cataract surgery in ocular cicatricial pemphigoid. Ophthalmology 1988;95:481-6.

104. Tauber J, Melamed S, Foster CS. Glaucoma in patients with ocular cicatricial pemphigoid. Ophthalmology 1989;96:33-7.

105. Singh G, Foster CS. Growth factors in treatment of nonhealing corneal ulcers and recurrent erosions. Cornea 1989;8:45-53.

106. Sainz de la Maza M, Tauber J, Foster CS. Scleral grafting for necrotizing scleritis. Ophthalmology 1989;96:306-10.

107. Phan T-MM, Foster CS, Wasson PJ, Fujikawa LS, Zagachin LM, Colvin RB. Role of fibronectin and fibrinogen in healing of corneal epithelial scrape wounds. Invest Ophthalmol Vis Sci 1989;30:377-85.

108. Phan T-MM, Foster CS, Zagachin LM, Colvin RB. Role of fibronectin in the healing of superficial keratectomies in vitro. Invest Ophthalmol Vis Sci 1989;30:386-91.

109. Gudmundsson OG, Ormerod LD, Kenyon KR, Glynn RJ, Baker AS, Haaf J, Lubars S, Abelson MB, Boruchoff SA, Foster CS, et al. Factors influencing predilection and outcome in bacterial keratitis. Cornea 1989;8:115-21.

110. Zaltas MM, Ahmed R, Foster CS. Association of HLA-DR4 with ocular cicatricial pemphigoid. Curr Eye Res 1989;8:189-93.

111. Foster CS, Opremcak EM, Tolchin N. Evidence for the potential influence of cyclic nucleotides on maintenance of or reactivation from latency of herpes simplex in trigeminal ganglionic neurons. Acta Ophthalmol 1989;67:142-4.

112. Liu EY, Raizman MB, Rosner B, Ihley TM, Foster CS. Effects of blood transfusion and cyclosporin on rabbit corneal graft survival. Curr Eye Res 1989;8:523-31.

113. Foster CS, Fong LP, Singh G. Cataract surgery and intraocular lens implantation in patients with uveitis. Ophthalmology 1989;96:281-8.

114. Raizman MB, Foster CS. Plasma exchange in the therapy of Behçet’s disease. Graefe’s Arch Clin Exp Ophthalmol 1989;227:360-3.

115. Opremcak EM, Foster CS, Hemady R, Rice BA, Daigle JA, Raizman MB, Chung H, Zaltas M. Chorioretinal disease patterns in congenic mice following intraocular inoculation with HSV-1. Invest Ophthal Vis Sci 1989;30:1041-6.

116. Hoang-Xuan T, Foster CS, Raizman MB, Greenwood B. Mast cells in conjunctiva affected by cicatricial pemphigoid. Ophthalmology 1989;96:1110-4.

117. Foster CS. Herpes simplex virus-induced destructive corneal disease. Eye 1989;3:194-203.

118. Ahmed AR, Khan KN, Wells PA, Rice BA, Foster CS. Preliminary serological studies comparing immunofluorescence assay with radioimmunoassay. Curr Eye Res 1989;8:1011-9.

119. Hemady R, Opremcak EM, Zaltas M, Berger A, Foster CS. Herpes simplex virus type-1 strain influence on chorioretinal disease patterns following intracameral inoculation in Igh-1 disparate mice. Invest Ophthalmol Vis Sci 1989;30:1750-7.

120. Sainz de la Maza M, Wells PA, Foster CS. Cyclic nucleotide modulation of herpes simplex virus latency and reactivation. Invest Ophthalmol Vis Sci 1989;30:2154-9.

121. Young LHY, Foster CS, Young JDE. In vivo expression of perforin by natural killer cells during a viral infection: studies on uveitis produced by herpes simplex virus type 1. Am J Pathol 1989;136:1021-30.

122. Sainz de la Maza M, Tauber J, Hoang-Xuan T, Foster CS. Consideraciones sobre la decision terapeutica en la queratitis ulcerativa periferica. Arch Soc Esp Oftal 1989;53:273-9.

123. Sainz de la Maza M, Foster CS. Posibilidades de manipulacion de las fases de latencia y reactivacion del virus herpes simplex tipo 1. Arch Soc Esp Oftal 1989;2:37-44.

124. Sainz de la Maza M, Foster CS. Nucleotidos ciclicos y reactivacion viral en un modelo de latencia del virus del herpes tipo I en el ganglio trigeminal del raton. Arch Soc Esp Oftal 1989;1:67-72.

125. Foster CS, Ross RN. Giant papillary conjunctivitis: the American experience. Proceedings of the Second Fison’s International Ophthalmology Workshop, Paris 1990;16-24.

126. Foster CS, Calonge MC. Management of severe atopic keratoconjunctivitis. Proceedings of the Second Fison’s International Ophthalmology Workshop, Paris1990;76-89.

127. Hemady R, Zaltas M, Paton B, Foster CS, Baker AS. Bacillus-induced endophthalmitis: new series of 10 cases and review of literature. Br J Ophthalmol 1990;74:26-9.

128. Hoang-Xuan T, Foster CS, Rice BA. Scleritis in relapsing polychondritis. Ophthalmology 1990;97:892-8.

129. Young LHY, Foster CS, Young JDE. In vivo expression of perforin by natural killer cells during a viral infection. Am J Path 1990;136:1021-30.

130. Hemady R, Chu W, Foster CS. Keratoconjunctivitis sicca and corneal ulcers. Cornea 1990;9:170-3.

131. Tauber J, Sainz de la Maza M, Hoang-Xuan T, Foster CS. An analysis of therapeutic decision making regarding immunosuppressive chemotherapy for peripheral ulcerative keratitis. Cornea 1990;9:66-73.

132. Hersh PS, Rice BA, Baer JC, Wells PA, Lynch SE, McGuigan LJB, Foster CS. Topical nonsteroidal agents and corneal wound healing. Arch Ophthalmol Vis Sci 1990;108:577-83.

133. Foster CS, Calonge M. Atopic keratoconjunctivitis. Ophthalmol. 1990;97:992-1000.

134. Singh G, Wilson MR, Foster CS. Long-term follow-up study of mitomycin eye drops as adjunctive treatment for pterygia and its comparison with conjunctival autograft transplantation. Cornea 1990;9:331-4.

135. Hoang-Xuan T, Rodriguez A, Zaltas M, Rice B, Foster CS. Ocular rosacea: a histologic and immunopathologic study. Ophthalmology 1990;97:1468-75.

136. Rice BA, Foster CS. Immunopathology of cicatricial pemphigoid affecting the conjunctiva. Ophthalmology 1990;97:1476-83.

137. Baer JC, Raizman MB, Foster CS. Ocular Behçet’s disease in the United States: clinical presentation and visual outcome in 29 patients. Ocul Immunol Today 1990;918:383-6.

138. Foster CS, Tauber J, Sainz de la Maza M. Systemic chemotherapy for ocular cicatricial pemphigoid. Ocul Immunol Today 1990;918:409-13.

139. Tamesis RR, Foster CS. Natural killer cellular cytoxicity against herpes simplex virus-infected cells in Igh-1-disparate mice. Invest Ophthalmol Vis Sci 1990;31:2224-9.

140. Hemady R, Tauber J, Ihley TM, Opremcak EM, Foster CS. Viral isolation and systemic immune responses after intracameral inoculation of herpes simplex virus type 1 in Igh-1-disparate congenic murine strains. Invest Ophthalmol Vis Sci 1990;31:2335-41.

141. Opremcak EM, Rice BA, Wells PA, Foster CS. Histology and immunohistology of Igh-1-restricted herpes simplex keratitis in BALB/c congenic mice. Invest Ophthalmol Vis Sci 1990;31:305-12.

142. Hoang-Xuan T, Baer J, Ihley TM, Rice BA, Wells PA, Foster CS. Anti-idiotypic vaccination against HSV-1 keratitis. Ocul Immunol Today 1990;918:115-8.

143. Tamesis RR, Foster CS. Natural killing of HSV-1 infected and noninfected target cells in Igh-1 disparate mice. Ocul Immunol Today 1990;918:157-60.

144. Sainz de la Maza M, Foster CS, Tauber J. Value of scleral homografting in necrotizing scleritis management. Ocul Immunol Today 1990;918:455-8.

145. Sainz de la Maza M, Foster CS, Fong LP, Rice BA. Immunohistochemical study of scleritis. Ocul Immunol Today 1990;918:309-12.

146. Hemady RK, Opremcak EM, Zaltas M, Tauber J, Foster CS. Igh-1 influence on development of HSV-1 retinitis in a mouse model. Ocul Immunol Today 1990;918:119-122.

147. Foster CS, Ihley TM, Hemady R, Tamesis RR, Rice BA, Wells PA. Role of antibody in prevention of herpes simplex stromal keratitis. Ocul Immunol Today 1990;918:111-4.

148. Foster CS. Intraocular lens implants in patients with uveitis. Ophthalmology 1990;97;12:1579.

149. Foster CS, Tauber J., Sainz de la Maza M, Hoang-Xuan T. Investigation and treatment of peripheral corneal ulcers. Fourth Workshop on External Eye Disease & Inflammation 1990;13-21.

150. Sainz de la Maza M, Foster CS, Rodriguez A. Tecnicas immunohistoquimicas en la latencia y reactivacion del virus herpes simplex tipo 1. Arch Soc Esp Oftal Invest 1990;3:17-24.

151. Sainz de la Maza M, Foster CS. Papel de los inmunocomplejos en la escleritis necrotizante. Arch Soc Oftal 1990;59:265-70.

152. Foster CS, Baer JC, Raizman MB. Therapeutic responses to systemic immunosuppressive chemotherapy agents in patients with Behçet’s syndrome affecting the eyes. Fifth International Symposium on Behçet’s Disease 1990;581-588.

153. Phan TM, Foster CS, Shaw CD, Zagachin LM, Colvin RB. Topical fibronectin in an alkali burn model of corneal ulceration in rabbits. Arch Ophthalmol 1991;109:414-9.

154. Hemady R, Tauber J, Foster CS. Immunosuppressive drugs in immune and inflammatory ocular disease. Surv Ophthalmol 1991;35:369-85.

155. Fong LP, Sainz de la Maza M, Rice BA. Kupferman AE, Foster CS. Immunopathology of scleritis. Ophthalmology 1991;98:472-9.

156. Tauber J, Sainz de la Maza M, Foster CS. Systemic chemotherapy for ocular cicatricial pemphigoid. Cornea 1991;10:185-95.

157. Zierhut M, Foster CS. Multiple sclerosis, sarcoidosis, and other diseases in patients with pars planitis. Dev Ophthalmol 1991;23:41-7.

158. Hoang-Xuan T, Foster CS, Jakobiec FA, Tauber J, Sainz de la Maza M, Krebs W. Romberg’s progressive hemifacial atrophy: an association with scleral melting. Cornea 1991;10:361-6.

159. Raizman MB, Sainz de la Maza M, Foster CS. Tectonic keratoplasty for peripheral ulcerative keratitis. Cornea 1991;10:312-6.

160. Neumann R, Tauber J, Foster CS. Remission and recurrence after withdrawal of therapy for ocular cicatricial pemphigoid. Ophthalmology 1991;98:858-62.

161. Lee SJ, Rice BA, Foster CS. HLA class II expression in normal and inflamed conjunctiva. Regional Immunology 1991;3:177-85.

162. Foster CS, Rice BA, Dutt J. Immunopathology of atopic keratoconjunctivitis. Ophthalmology 1991;98:1190-6.

163. Sainz de la Maza M, Foster CS, Raizman MB. Queratoplastia tectonica en queratitis ulcerativa periferica. Arch Soc Esp Oftal 1991;60:189-92.

164. Sainz de la Maza M, Foster CS. The diagnosis and treatment of peripheral ulcerative keratitis. Semin Ophthalmol 1991;6:133-41.

165. Rodriguez A, Sainz de la Maza M, Missry J, Foster CS. The role of cyclic nucleotide mediators in latency and reactivation of HSV-1 infected neuroblastoma cells. Eye 1991;5:627-35.

166. Sainz de la Maza M, Foster CS. Necrotizing scleritis after ocular surgery: A clinopathologic study. Ophthalmology 1991;98:1720-6.

167. Zierhut M, Tamesis R, Foster CS. Herpes-simplex-Virus-Retinitis. Fortchr Ophthalmol 1991;88:740-7.

168. Foster CS. Cataract surgery and intraocular lens implantation in patients with intermediate uveitis. Dev Ophthalmol 1992;23:212-8.

169. Foster, CS. Medical treatment of intermediate uveitis. Dev Ophthalmol 1992;23:156-7.

170. Zaltas MM, Opremcak EM, Hemady R, Foster CS. Immunohistologic findings in herpes simplex virus chorioretinitis in the Von Szily mModel. Invest Ophthalmol Vis Sci 1992;33:68-77.

171. Chan LS, Soong HK, Foster CS, Hammerberg C, Cooper KD. Ocular cicatricial pemphigoid occurring as a sequela of Stevens-Johnson syndrome. J Am Med Assoc 1991;266:1543-6.

172. Ahmed AR, Foster CS, Zaltas M, Notani O, Awdeh Z, Alper CA, Yunis EJ. Association of DQw7 (DQB1*0301) with OCP. Proc Nat Acad Sci 1991;88:11579-82.

173. Baer JC, Foster CS. Corneal laser photocoagulation for treatment of neovascularization: Efficacy of 577 nm yellow dye laser. Ophthalmology 1992;99:173-9.

174. Soukiasian SH, Foster CS, Niles JL, Raizman MB. Diagnostic value of anti-neutrophil cytoplasmic antibodies in scleritis associated with Wegener’s granulomatosis. Ophthalmology 1992;99:125-32.

175. Soukiasian SH, Rice BA, Foster CS, Lee SJ.. The T cell receptor in normal and inflamed human conjunctiva. Invest Ophthalmol Vis Sci 1992;33:453-9.

176. Foster CS, Zierhut M, Wu H, Tamesis R, Jabbur N. Murine acute retinal necrosis. Trans Am Ophthalmol Soc 1992;251-268.

177. Calonge M, Foster CS, Rice BA, Baer JC. Management of corneal complications in xeroderma pigmentosum. Cornea 1992;11:173-82.

178. Shore JW, Foster CS, Westfall CT, Rubin PA. Results of buccal mucosal grafting for patients with medically controlled ocular cicatricial pemphigoid. Ophthalmology 1992;99:383-95.

179. Hemady RK, Baer JC, Foster CS. Immunosuppressive drugs in the management of progressive, corticosteroid-resistant uveitis associated with juvenile rheumatoid arthritis. Int Ophthalmol Clin 1992;32:2410-52.

180. Okada AA, Foster CS. Posterior uveitis in the pediatric population. Int Ophthalmol Clin.1992;32:121-52.

181. Hemady RK, Sainz de la Maza M, Raizman MB, Foster CS. Six cases of scleritis associated with systemic infection. Am J Ophthalmol 1992;114:55-62.

182. Hemady RK, Chu W, Foster CS. Intraocular penetration of ketoconazole in rabbits. Cornea 1992;11:329-33.

183. Tauber J, Jabbur N, Foster CS. Improved detection of disease progression in ocular cicatricial pemphigoid. Cornea 1992;11:446-51.

184. Elner VM, Dutt J, Pavilack MA, Sugar A, Foster CS, Elner SG. Intercellular adherence molecule-1 (ICAM-1) and HLA-DR antigens in herpes keratitis. Ophthalmology 1992;99:1400-7.

185. Filipec M, Mai Phan T, Zhao T, Rice BA, Merchant A, Foster CS. Topical cyclosporine A and corneal wound healing. Cornea 1992;11:546-52.

186. Zierhut M, Soukiasian S, Zhao T, Tamesis RR, Foster CS. Depletion of T-lymphocyte subsets in murine herpes-simplex-virus retinitis. German J Ophthalmol 1992;1:145-50.

187. Sainz de la Maza M, Jabbur NS, Foster CS. Esclero-uveitis. Arch Soc Esp Oftal 1992;63:1-8.

188. Rubinfeld RS, Pfister RR, Stein RM, Foster CS, Martin NF, Stoleru S, Talley AR, Speaker MG. Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology 1992;99:1647-54.

189. Foster CS, Barney NP. Systemic acyclovir and penetrating keratoplasty for herpes simplex keratitis. Documenta Ophthalmologica 1992;80:363-9.

190. Haider N, Neumann R, Foster CS, Ahmed AR. Report on the sequence of DQB1*0301 gene in ocular cicatricial pemphigoid patients. Curr Eye Res 1992;11:1233-8.

191. Foster CS, Neumann R, Tauber J. Long term results of systemic chemotherapy for ocular cicatricial pemphigoid. Documenta Ophthalmologica 1993;82:223-9.

192. Pavilack MA, Foster CS, Kowal VO, Dutt JE, Albert DM. Peripseudophakic membrane: pathologic features. Arch Ophthalmol 1993;111:240-4.

193. Foster CS, Vitale AT. Cataract surgery in uveitis. Ophthalmol Clin North Am 1993;6:139-46.

194. Neumann R, Dutt J, Foster, CS. Immunohistopathologic features and therapy of conjunctival lichen planus. Am J Ophthalmol 1993;115:494-500.

195. Hemady RK, Baer JC, Foster CS. Biomicroscopic and histopathologic observations after corneal laser photocoagulation in a rabbit model of corneal neovascularization. Cornea 1993;12:185-90.

196. Zierhut M, Foster CS. Role of T-lymphocyte subsets in murine herpes simplex virus retinitis. Recent advances in uveitis. Proceedings of the Third International Symposium on Uveitis1993;29-32.

197. Foster CS, Baer J. Behçet’s disease in America: ocular manifestations and response to treatment. Recent advances in uveitis. Proceedings of the Third International Symposium on Uveitis 1993;185-189.

198. Foster CS, Hunter D. Isolated ocular sarcoidosis: Late development of systemic manifestations in uveitis patients. Recent advances in uveitis. Proceedings of the Third International Symposium on Uveitis. 1993;377-9.

199. Zierhut M, Foster CS. Uveitis and relapsing polychondritis. Recent advances in uveitis. Proceedings of the Third International Symposium on Uveitis 1993;487-9.

200. Foster CS, Hemady RK, Baer JC. Cytotoxic agents in the management of juvenile theumatoid arthritis (JRA) associated uveitis. Recent advances in uveitis. Proceedings of the Third International Symposium on Uveitis 1993;525-8.

201. Foster CS. Cataract surgery and intraocular lens implantation in patients with pars planitis. Recent advances in uveitis. Proceedings of the Third International Symposium on Uveitis 1993;593-5.

202. Foster CS, Wu HK, Merchant A. Systemic (serum) soluble interleukin-2 receptor levels in corneal transplant recipients. Documenta Ophthalmologica 1993;83:83-90.

203. Neumann R, Jabbur NS, Vickers F, Foster CS. Topical diclofenac sodium, dexamethasone and placebo compared in a model of immunogenic uveitis in rabbits. Ocul Immunol Inflamm 1993;1:87-97.

204. Barney NP, Foster CS. Atopic ocular disease. Int Ophthalmol Clin 1993;33:87-92.

205. Foster CS, Barrett F. Cataract development and cataract surgery in patients with juvenile rheumatoid arthritis-associated iridocyclitis. Ophthalmology 1993;100:809-17.

206. Kaufman AH, Foster CS. Cataract extraction in patients with pars planitis. Ophthalmology 1993;100:1210-7.

207. Sainz de la Maza M, Jabbur NS, Foster CS. An analysis of therapeutic decision for scleritis. Ophthalmology 1993;100:1372-6.

208. Heiligenhaus A, Shore JW, Rubin PAD, Foster CS. Long-term results of mucous membrane grafting in ocular cicatricial pemphigoid: Implications for patient selection and surgical considerations. Ophthalmology 1993;100:1283-8.

209. Akova YA, Jabbur NS, Neumann R, Foster CS. Atypical ocular atopy. Ophthalmology 1993;100:1367-71.

210. Tamesis RR, Rodriguez AG, Hoang-Xuan T, Foster CS. Antibody-dependent cellular cytoxicity against cells infected with herpes simplex virus type 1 in Igh-1 disparate congenic mice. German J Ophthalmol 1993;2:218-23.

211. Sainz de la Maza M, Hemady RK, Foster CS. Infectious scleritis: Report of four cases. Documenta Ophthalmologica 1993;33-41.

212. Mohimen A, Neumann R, Foster CS, Ahmed AR. Detection and partial characterization of ocular cicatricial pemphigoid antigens on COLO and SCaBER tumor cell lines. Curr Eye Res 1993;12:741-52.

213. Soukiasian SH, Foster CS. Mooren’s ulcer. Diagnostic problems in clinical ophthalmology 1994;220-227.

214. Foster CS. Author’s Reply: Cataract surgery in patients with juvenile rheumatoid arthritis. Ophthalmology 1993;100:1597.

215. Akova YA, Dutt J, Rodriguez A, Jabbur N, Foster CS. The Role of Igh-1 Disparate congenic mouse T lymphocytes in the pathogenesis of herpetic stromal keratitis. Curr Eye Res 1993;12:1093-101.

216. Jayaraman S, Heiligenhaus A, Rodriguez A, Soukiasian S, Dorf ME, Foster CS. Exacerbation of murine herpes simplex virus-mediated stromal keratitis by Th2 type T cells. J Immunol 1993;151:5777-89.
217. Foster CS. Pars planitis. American Academy of Uveitis Module: Focal Points 1993;11:8-10.

218. Akova YA, Foster CS. Cataract surgery in patients with sarcoidosis-associated uveitis. Ophthalmology 1993;101:473-9.

219. Foster CS, Rodriguez-Garcia A, Pedroza-Seres M, Berra A, Heiligenhaus A, Soukiasian SH, Jayaraman S. Murine herpes simplex virus keratitis is accentuated by CD4+, Vß 8.2+ Th2 T cells. Trans Am Ophthalmol Soc 1993;91:325-350.

220. Berra A, Dutt JE, Nouri M, Foster CS. Heat shock protein expression in human conjunctiva. Invest Ophthalmol Vis Sci 1994;35:352-7.

221. Sainz de la Maza M, Jabbur NS, Foster CS. Severity of scleritis and episcleritis. Ophthalmology 1994;101:389-96.

222. Foster CS, Soukiasian SH. Anti-neutrophil cytoplasmic antibodies (ANCA) scleritis. Documenta Ophthalmologica 1993.

223. Sainz de la Maza M, Jabbur NS, Foster CS. Tratamiento de la escleritis (scleritis therapy). Arch Soc Españ Oftalmol 1993;64:261-26.

224. Santos CI, Huang AJ, Abelson MB, Foster CS, Friedlander M, McCulley JP. Efficacy of lodoxamide 0.1% ophthalmic solution in resolving corneal epitheliopathy associated with vernal keratoconjunctivitis. Am J Ophthalmol 1994;117:488-97.

225. Barney NP, Foster CS. A prospective randomized trial of oral acyclovir following penetrating keratoplasty for herpes simplex keratitis. Cornea 1994;13:232-6.

226. Holland GN, Executive Committee of American Uveitis Society. Perspective: standard diagnostic criteria for the acute retinal necrosis syndrome. Am J Ophthalmol 1994;117:663-7.

227. Sainz de la Maza M, Dutt JE, Foster CS. Comparacion de los componentes de la Matriz extracellular entre la esclera normal y la esclera con inflamacion necrotizante. Arch Soc Esp Oftal 1994;66:59-64.

228. Vitale AT, Rodriguez A, Foster CS. Low-dose cyclosporine therapy in the treatment of birdshot retinochoroidopathy. Ophthalmology 1996;103:365-73.

229. Espaillat A, Lee SJ, Arrunategui-Correa V, Foster CS, Vitale A, Dimeo S, Colvin RB. Expression of fibronectin isoforms in a rat cornea after an epithelial-scrape wound. Curr Eye Res 1994;13:325-30.

230. Sainz de la Maza M, Foster CS. Peripheral ulcerative keratitis and malignancies. Cornea 1994;13: 364-7.

231. Cai X, Foster CS, Lui JJ, Filipec M, Kupferman AE, Colvin RB, Lee SJ. Alternatively spliced fibronectin molecules in the wounded cornea: analysis by polymerase chain reaction. Invest Ophthalmol Vis Sci 1993;34:3585-92.

232. Lee SJ, Li Z, Sherman B, Foster CS. Serum levels of tumor necrosis factor-alpha and interleukin-6 in ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci 1993;34:3522-5.

233. Akova Y, Jabbur N, Foster CS. Ocular presentation of polyarteritis nodosa: clinical course and management with steroid and cytotoxic therapy. Ophthalmology 1993;100:1775-81.

234. Zierhut M, Hemady R, Zhao T, Ihley TA, Merchant A, Foster CS. Herpes simplex virus type 2 induced retinal necrosis in BALB/c mice. Acta Ophthalmologica 1993;72:211-7.

235. Berra A, Rodriguez A, Heiligenhaus A, Pazos B, Van Rooijen N, Foster CS. The role of macrophages in the pathogenesis of HSV-1 induced chorioretinitis in BALB/c mice. Invest Ophthalmol Vis Sci 1994;35:2990-8.

236. Tamesis RR, Messmer EM, Rice BA, Dutt JE, Foster CS. The role of natural killer cells in the development of herpes simplex virus type-1 induced stromal keratitis. Eye 1994;8:298-306.

237. Neumann R, Foster CS. Experimental uUveitis. Ocul Immunol Inflamm1993;1:87-97.

238. Lane L, Ayliffe W, Foster CS. Management strategies in peripheral ulcerative keratitis and necrotizing scleritis. Proceedings, New Orleans Academy of Ophthalmology 1993;39-47.

239. Ayliffe W, Foster CS. High risk keratoplasty. Proceedings, New Orleans Academy of Ophthalmology 1993;57-69.

240. Foster CS. Cataract surgery in the patient with uveitis. American Academy of Ophthalmology Module: Focal Points 1994;12:1-6.

241. Foster CS, Dutt JE, Rice BA, Kupferman AE, Lane L. Conjunctival epithelial basement membrane zone immunohistology: normal and inflamed conjunctiva. Int Ophthalmol Clin 1993;34:209-14.

242. Kaufman AH, Niles JL, Foster CS. ANCA test in ophthalmic inflammatory disease. Int Ophthalmol Clin 1994;34:215-27.

243. Park SS, D’Amico DJ, Foster CS. The role of invasive diagnostic testing in inflammatory eye diseases. Int Ophthalmol Clin 1994;34:229-38.

244. Akova YA, Rodriguez A, Foster CS. Atopic keratoconjunctivitis. Ocul Immunol Inflamm1994;2:125-44.

245. Vitale AT, Pedroza-Seres M, Arrunategui-Correa V, Lee SJ, Dimeo S, Foster CS, Colvin RB. Differential expression of alternatively spliced fibronectin in normal and wounded rat corneal stroma and epithelium. Invest Ophthalmol Vis Sci 1994;35:3664-72.

246. Yunis JJ, Mobini N, Yunis EJ, Alper CA, Deulofeut R, Rodriguez A, Foster CS, Marcus-Bagley D, Good RA, Ahmed AR. Common major histocompatibility complex class II markers in clinical variants of cicatricial pemphigoid. Proc Natl Acad Sci 1994;91:7747-51.

247. Zierhut M, Tamesis RR, Neumann R, Hemady R, Ihley TM, Dutt JE, Zhao T, Foster CS. Herpes-simplex-Virus-Retinitis: Rolle des Immunsystems im Tierversuch (Natural killer cells do not influence the von Szily model of herpes simplex virus type-1 induced contralateral retinitis). Ger J Ophthalmol 1991;88:740-7.

248. Rodriguez A, Akova YA, Pedroza-Seres M, Foster CS. Posterior segment ocular manifestations in patients with HLA-B27-associated uveitis. Ophthalmology 1994;101:1267-74.

249. Merayo-Lloves J, Foster CS. Murine model of seasonal allergic conjunctivitis (SAC) to ragweed. Excerpta Medica 1994;107-10.

250. Pedroza-Seres M, Goei S, Merayo-Lloves J, Arrunategui-Correa V, Foster CS.. Expression of Vß T cell receptor transcripts in experimental murine keratitis. Excerpta Medica 1994;293-6.

251. Neves RA, Rodriguez A, Power WJ, Pedroza-Seres M, Foster CS. The value of combined serum angiotensin converting enzyme and gallium scan in the diagnosis of ocular sarcoidosis. Excerpta Medica 1994;353-6.

252. Power WJ, Rodriguez A, Neves RA, Lane L, Foster CS. Prognostic value of antineutrophil cytoplasmic antibodies in limited ocular Wegener’s granulomatosis. Excerpta Medica 1994;365-8.

253. Sainz de la Maza M, Foster CS. Ocular prognosis of scleritis and systemic vasculitic diseases. Excerpta Medica 1994;373-6.

254. Foster CS, Drake M, Turner FD, Crabb JL, Santos CI, et al.. Efficacy and safety of 1% rimexolone ophthalmic suspension vs. 1% prednisolone acetate (Pred Forte). Excerpta Medica 1994;411-5.

255. Neves RA, Dutt JE, Rodriguez A, Merayo-Lloves J, Belfort R, Foster CS. Immunohistopathology of the lacrimal gland in AIDS-related sicca syndrome. Excerpta Medica 1994;453-6.

256. Rodriguez A, Power WJ, Neves RA, Foster CS. Long-term systemic acyclovir in the management of recurrent herpes simplex keratouveitis. Excerpta Medica 1994;465-8.

257. Arrunategui-Correa VR, Dutt JE, Foster CS. The role of B lymphocytes in experimental herpes simplex viral retinitis. Scand J Immunol 1994;40:299-307.

258. Sainz de la Maza M, Foster CS, Jabbur NS. Scleritis associated with rheumatoid arthritis and with other systemic immune-mediated diseases. Ophthalmology 1994;101:1281-6.

259. Heiligenhaus A, Berra A, Foster CS. CD4+ Vß8+ T cells mediate herpes stromal keratitis. Curr Eye Res 1994;13:711-6.

260. Soukiasian SH, Foster CS, Raizman MB. Treatment strategies for scleritis and uveitis associated with inflammatory bowel disease. Am J Ophthalmol 1994;118:601-11.

261. Power WJ, Rodriguez A, Neves RA, Lane L, Foster CS. Disease relapse in patients presenting with ocular manifestations of Wegener’s granulomatosis. Ophthalmology 1995;102:154-60.

262. Power WJ, Foster CS. Update on sympathetic ophthalmia. Int Ophthalmol Clin 1995;35:127-37.

263. Ayliffe W, Foster CS, Marcoux P, Upton M, Finkelstein M, Kuperwaser M, Legmann A. Relapsing acute myeloid leukemia presenting as hypopyon uveitis. Am J Ophthalmol 1995;119:361-4.

264. Bhol K, Udell I, Haider N, Yunis JJ, Mohimen A, Neumann R, Grasso C, Ahmed AR, Foster CS. Ocular cicatricial pemphigoid: A case report of monozygotic twins discordant for the disease. Arch Ophthalmol 1995;113:202-7.

265. Foster CS. The pathophysiology of ocular allergy: current thinking. Allergy 1995;50:6-9.

266. Tugal-Tutkun I, Akova YA, Foster CS. Penetrating keratoplasty in cicatrizing conjunctival diseases. Ophthalmology 1995;102:576-85.

267. Sainz de la Maza M, Foster CS, Jabbur NS. Scleritis associated with systemic vasculitic diseases. Ophthalmology 1995;102:687-92.

268. Foster CS. Round Table: The chronic red eye. Proceedings, New Orleans Academy of Ophthalmology 1993;143-11.

269. Foster CS, Ledoux D. Types and management of ophthalmic herpes simplex virus infections. Herpes 1995;2:27-32.

270. Merayo-Lloves J, Calonge M, Foster CS. Experimental model of allergic conjunctivitis to ragweed in guinea pig. Curr Eye Res 1995;14:487-94.

271. Messmer EM, Foster CS. Destructive corneal and scleral disease associated with rheumatoid arthritis: Medical and durgical management. Cornea 1995;14:408-17.

272. Sainz de la Maza M, Foster CS. Asociationes sistémicas de la escleritis. Arch Soc Espan Oftalmol 1995;68:581-6.

273. Talamo JH, Siebert K, Wagoner MD, Yeh E, Telfair W. VISX moderate myopia study group. Multicenter study of photorefractive keratectomy for myopia of 6.00 to 8.00 diopters. J Refract Surg 1995;11:238-47.

274. Rodriguez Garcia A, Foster CS. Infecciones oculares en pacientes con el síndrome de immunodeficiencia adquirida. Enfermedades Infecciosas y Microbiologia; 1995;14:407-15.

275. Power WJ, Neves RA, Rodriguez A, Dutt JE, Foster CS. Increasing the diagnostic yield of conjunctival biopsy in patients with suspected ocular cicatricial pemphigoid. Ophthalmology 1995;102:1158-63.

276. Lane L, Tamesis R, Rodriguez A, Christen W, Akova YA, Messmer E, Pedroza-Seres M, Barney N, Foster CS. Systemic immunosuppressive therapy and the occurrence of malignancy in patients with ocular inflammatory disease. Ophthalmology 1995;102:1530-5.

277. Tugal-Tutkun I, Urgancioglu M, Foster CS. Immunopathologic study of the conjunctiva in patients with Behçet’s disease. Ophthalmology 1995;102:1660-8.

278. Power WJ, Ghoraishi M, Merayo-Lloves J, Neves RA, Foster CS. Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum. Ophthalmology 1995;102:1669-76.

279. Avery AC, Zhao Z, Rodriguez A, Bikoff E, Soheilian M, Foster CS, Cantor H. Resistance to herpes stromal keratitis conferred by an IgG2a-derived peptide. Nature 1995;376:431-4.

280. Foster CS. Clinician’s corner (contributor). American Academy of Ophthalmology Module: Focal Points 1995;13:10-4.

281. Neumann RR, Foster CS. Corticosteroid-sparing strategies in the treatment of retinal vasculitis in systemic lupus erythematous patients. Retina 1995;15:206-12.

282. Correa VA, Dutt JE, Foster CS. Variable region usage in B cell deficient mice in the model of experimental herpes simplex retinitis. Scand J Immunol 1995;42:387-95.

283. Ghoraishi M, Akova YA, Tutkun IT, Foster CS. Penetrating keratoplasty in atopic keratoconjunctivitis. Cornea 1995;14:610-3.

284. Heiligenhaus A, Jayaraman S, Soukiasian S, Dorf M, Foster CS. Glykoprotein D (5-23) spezifische Th2 T-Zell Linie induziert HSV-1 Keratitis. Der Ophthalmologe 1995;92:484-91.

285. Heiligenhaus A, Foster CS. Histological and immunopathological analysis of T-cells mediating murine HSV-1 keratitis. Graefe’s Arch Clin Exp Ophthalmol 1994;232:628-34.

286. Heiligenhaus A, Wells PA, Foster CS. Immunization against HSV 1 keratitis with a synthetic gD peptide. Eye 1995;9:89-95.

287. Sainz de la Maza M, Foster CS. Inflamación escleral. Inflamaciones oculares. Official report of the Spanish Ophthalmological Society 1995;213-234.

288. Rodriguez A, Power WJ, Neves RA, Foster CS. Recurrence rate of herpetic keratouveitis in patients on long-term oral acyclovir. Documenta Ophthalmologica 1995;90:331-40.

289. Power WJ, Neves RA, Rodriguez A, Pedroza-Seres M, Foster CS. The value of combined serum angiotensin converting enzyme and gallium scan in the diagnosis of ocular sarcoidosis. Ophthalmology 1995;102:2007-11.

290. Rodriguez-Garcia A, Foster, CS. Valor diagnóstico y terapéutico de la biopsia conjunctival en las enfermedades inflamatorias oculares externas. Rev Mex Oftalmol 1995;69:221-8.

291. Power WJ, Kaufman AH, Merayo-Lloves J, Arrunategui-Correa V, Foster CS. Expression of collagens I, III, IV and V mRNA in excimer wounded rat cornea: analysis by semi-quantitative PCR. Curr Eye Res 1995;14:879-86.

292. Tugal-Tutkun I, Havrlikova K, Power WJ, Foster CS. Changing patterns in uveitis of childhood. Ophthalmology 1996;103:375-83.

293. Pedroza-Seres M, Goei S, Merayo-Lloves J, Arrunategui-Correa V, Dutt J, Foster CS. T-cell receptor Vß gene expression in experimental herpes stromal keratitis. Eye 1995;9:599-604.

294. Talamo JH, Siebert K, Wagoner MD, et al. Multicenter study of photorefractive keratectomy for myopia of 6.00 to 8.00 Diopters. J Refractive Surg 1995;11:238-47.

295. Berra A, Dutt JE, Foster CS. Detection of herpes simplex virus type 1 by an in situ polymerase chain reaction technique. Cornea 1996;15:55-61.

296. Rodriguez A, Calonge M, Pedroza-Seres M, Akova YA, Messmer E, D’Amico DJ, Foster CS. Referral patterns of uveitis in a tertiary care center: An epidemiologic study. Arch Ophthalmol 1996;114:593-600.

297. Merayo-Lloves J, Dutt JE, Zhao T, Foster CS. A new murine model of allergic conjunctivitis and effectiveness of nedocromil sodium. J All Clin Immunol 1996;97:1129-40.

298. Sainz de la Maza M, Bujan A, Foster CS, Ayliffe W. Sequedad ocular en pacientes con la enfermedad crónica del injerto contra el huésped. Arch Soc Espan Oftalmol 1996;70:57-64.

299. Chow CYC, Foster CS. Mooren’s ulcer. Int Ophthalmol Clin 1996;36:1-13.

300. Gregory JK, Foster CS. Peripheral ulcerative keratitis in the collagen vascular diseases. Int Ophthalmol Clin 1996;36:21-30.

301. Nguyen QD, Foster CS. Cicatricial pemphigoid: diagnosis and treatment. Int Ophthalmol Clin 1996;36:41-60.

302. Legmann A, Foster CS. Noninfectious necrotizing scleritis. Int Ophthalmol Clin 1996;36:73-80.

303. Ceisler EJ, Foster CS. Juvenile rheumatoid arthritis and uveitis: Minimizing the blinding complications. Int Ophthalmol Clin 1996;36:91-107.

304. Smith JA, Foster CS. Sarcoidosis and its ocular manifestations. Int Ophthalmol Clin 1996;36:109-25.

305. Bhisitkul RB, Foster CS. Diagnosis and ophthalmological features of Behçet’s disease. Int Ophthalmol Clin 1996;36:127-34.

306. Samiy N, Foster CS. The role of nonsteroidal antiinflammatory drugs in ocular inflammation. Int Ophthalmol Clin 1996;36:195-206.

307. Tamesis RR, Rodriguez A, Christen WG, Akova YA, Messmer E, Foster CS. Systemic drug toxicity trends in immunosuppressive therapy of immune and inflammatory ocular disease. Ophthalmology 1996;103:768-75.

308. Bhol K, Mohimen A, Neumann R, Yunis J, Foster CS, Yunis EJ, Ahmed AR. Difference in the anti-basement membrane zone antibodies in ocular and pseudo-ocular cicatricial pemphigoid. Curr Eye Res 1996;15:521-32.

309. Foster CS. Revoluntionary discoveries lead to diagnosis and cure. Ophthalmol World News 1995;17.

310. Buhac J, Bhol K, Padilla T, Foster CS, Ahmed AR. Coexistence of pemphigus vulgaris and ocular cicatricial pemphigoid. J Am Acad Dermatol 1996;34:884-6.

311. Soheilian M, Markomichelakis N, Foster CS. Intermediate uveitis and retinal vasculitis: New ocular manifestations of cat scratch disease. Am J Ophthalmol 1996;122:582-4.

312. Foster CS, Alter G, Crabb JL, DeBarge LR, Feiler L, Friedlander MH, Raizman MB, Santos CI. Efficacy and safety of rimexolone 1% ophthalmic suspension versus Pred Forte 1% in the treatment of uveitis. Am J Ophthalmol 1996;122:171-82.

313. Power WJ, Saidman SL, Zhang DS, Vamvakas EC, Merayo-Lloves JM, Kaufman AH, Foster CS. HLA typing in patients with ocular manifestations of Stevens-Johnson syndrome. Ophthalmology 1996;103:1406-9.

314. Dutt JE, Ledoux D, Baer H, Foster CS. Collagen abnormalities in conjunctiva of patients with cicatricial pemphigoid. Cornea 1996;15:606-11.

315. Neves RA, Rodriguez A, Power WJ, Muccioli C, Lane L, Belfort R, Foster CS. Herpes zoster peripheral ulcerative keratitis in patients with the acquired immunodeficiency syndrome. Cornea 1996;15: 446-50.

316. Dana MR, Merayo-Lloves J, Foster CS. Prognosticators for visual outcome in sarcoid uveitis. Ophthalmology 1996;103:1846-53.

317. Heiligenhaus A, Dutt JE, Foster CS. Histology and immunopathology of systemic lupus erythematosus affecting the conjunctiva. Eye 1996;10:425-32.

318. Rojas B, Foster CS. Cataract surgery in patients with uveitis. Curr Opin Ophthalmol 1996;7:11-6.

319. Berra A, Heiligenhaus A, Foster CS. T cell subsets and T cell receptor Vß utilization by Igh-1 congenic mice in herpetic retinal necrosis. Graefe’s Arch Clin Exp Ophthalmol 1996;234:583-8.

320. Zierhut M, Bieber T, Bröcker E, Forrester J, Foster CS, Streilein W. Trends in immunology. Immunol Today 1996;17:448-50.

321. Sainz de la Maza M, Foster CS, Jabbur NS. Scleritis-associated uveitis. Ophthalmology 1996;104:58-63.

322. Foster CS. Juvenile rheumatoid arthritis-associated uveitis: The continuing saga of preventable blindness. Ophthalmology Times 1996.

323. Foster CS. Rimexolone is the first new corticosteroid for ophthalmic use in 20 years – Its use controls inflammation without significantly raising intraocular pressure. Ocul Surg News 1996;14:124-5.

324. Dana MR, Merayo-Lloves J, Schaumberg DA, Foster CS. Visual outcome prognosticators in juvenile rheumatoid arthritis-associated uveitis. Ophthalmology 1997;104:236-44.

325. Power WJ, Hogan RN, Hu S, Foster CS. Primary varicella keratitis: diagnosis by PCR. Am J Ophthalmol 1996;123:252-4.

326. Abad JC, Foster CS. Fungal keratitis. Int Ophthal. Clin 1996;36:1-15.

327. Rojas B, Zafirakis P, Foser CS. Cataract surgery in patients with uveitis. Curr Opin Ophthalmol 1996;8:6-12.

328. Tyagi S, Bhol K, Natarajan K, Livir-Rallatos C, Hemler M, Foster CS, Ahmed AR. Ocular cicatricial pemphigoid antigen: Partial sequence and characterization. Proc Natl Acad Sci USA 1996;93:14714-9.

329. Sainz de la Maza M, Tarrus S, Foster CS. Tratamiento de la episcleritis recurrente. Arch Soc Esp Oftalmol 1997;72:17-22.

330. Sangwan VS, Zafirakis P, Foster CS. Mooren’s ulcer. Ind J Ophthalmol 1997;45:7-17.

331. Rodriguez A, Yood RA, Condon TJ, Foster CS. Recurrent uveitis in a patient with adult-onset cyclic neutropenia associated with increased large granular lymphocytes. Br J Ophthalmol 1997;81:415

332. Nussenblatt RB, Gery I, Ferris F, Weiner H, Shiloach J, Ramaley N, Perry C, Caspi R, Hafler D, Foster CS, Whitcup SM. Treatment of uveitis by oral administration of retinal antigens: Results of a phase I/II randomized masked trial. Am J Ophthalmol 1997;123:583-92.

333. Yang J, Foster CS. Rimexolone: A new ophthalmic corticosteroid with low intraocular pressure raising potenital. Drugs of Today 1997;33:123-9.

334. Foster CS. The role of ocular immunology in the twenty-first century. Arch Soc Esp= Oftalmol 1997;72:4.

335. Akpek EK, Merchant A, Pinar V, Foster CS. Ocular rosacea. Patient characteristics and follow-up. Ophthalmology 1998;04:1863-7.

336. Taravella MJ, Johnson DW, Petty JG, Keyser RB, Foster CS, Lundberg BE. Infectious posterior scleritis vaused by Pseudallescheria boydii: Clinicopathologic findings. Ophthalmology997;04:1312-6

337. Hu S, Dutt J, Zhao T, Foster CS. Tetrandrine potently inhibits herpes simplex virus type-2-induced keratitis in BALB/C mice. Oculmmunol Inflamm 1997;:173-180.

338. Arrunatequi-Correa V, Dutt JE, Foster CS. Analysis of T cell receptor V? gene expression in B cell deficient mice after experimental herpes simplex virus keratitis. Acta Virologica 1997;1:145-52.

339. Foster CS. Topical steroid treatment of ocular inflammation. Ophthalmol Clin North Am 1997;10:389-403.

340. Reza Dana M, Chatzistefanou K, Schaumberg DA, Foster CS. Posterior capsule opacification after cataract surgery in patients with uveitis. Ophthalmology 1997;104:1387-94.

341. Foster CS. A new steroid for treating postoperative ophthalmic inflammation and uveitis. Ophthalmic Practice 1997;15:117-8.

342. Foster CS. Necrology of Dr. Garrett Sullivan. Trans Am Ophthalmol Soc 1996;94:15-6.

343. Merchant A, Foster CS. Primary intraocular lymphoma (CNC-NHL). Int Ophthalmol Clin 1997;37:101-16.

344. Yang J, Foster CS. Squamous cell carcinoma of the conjunctiva. Int Ophthalmol Clin 1997;37:73-86.

345. Merchant A, Fletcher J, Medina CA, Hemady R, Foster CS. Pharmacomanipulation of HSV-1 induced chorioretinitis in mice. Eye 1997;11:504-5.

346. Hu S, Merayo-Lloves J, Zhao T, Foster CS. Potent inhibitory effect of tetrandrine on experimental allergic conjunctivitis in mice. J Ocul Pharmacol Therapeut 1997;13:435-44.

347. Abad JC, An B, Power WJ, Foster CS, Azar DT, Talamo JH. A prospective evaluation of alcohol-assisted vs. mechanical epithelial removal before photorefractive keratectomy (PRK). Ophthalmology 1997;104:1566-75.

348. Foster CS. Systemic lupus erythematosus, discoid lupus erythematosus, and progressive systemic sclerosis. Int Ophthalmol Clin 1998;37: 93-116.

349. Harper S, Foster CS. Rheumatoid disease and the eye. Int Ophthalmol Clin 1998;38:1-19.

350. Shiuey Y, Foster CS. Peripheral ulcerative keratitis and collagen vascular disease. Int Ophthalmol Clin 1998;38:21-32.

351. Nguyen QD, Foster CS. Systemic lupus erythematosus and the eye. Int Ophthalmol Clin 1998;38:33-60.

352. Krzystolik M, Power WJ, Foster CS. Ocular manifestations of sarcoidosis. Int Ophthalmol Clin 1998;38:61-76.

353. Chatzistefanou K, Markomichelakis N, Christen W, Soheilian M, Foster CS. Characteristics of uveitis presenting for the first time in the elderly. Ophthalmology 1998;105:347-52.

354. Power WJ, Tugal-Tutkun I, Foster CS. Long-term follow-up of patients with atopic keratoconjunctivitis. Ophthalmology 1998;105:637-42.

355. Heiligenhaus A, Schaller J, Mauß S, Engelbrecht S, Dutt JE, Foster CS, Steuhl K. Eosinophil granule proteins expressed in acute ocular cicatricial pemphigoid. Br J Ophthalmol 1998;82:312-7.

356. Foster CS. Recognizing the ocular manifestations of rheumatoid arthritis. Women’s Health 1998;1:247-57.

357. Hu S, Merayo-Lloves J, Zhao T, Foster CS. Comparative effectiveness and molecular pharmacological mechanisms of antiallergic drugs on experimental conjunctivitis in mice. J Ocul Pharmcol Therapeut 1998;14:67-74.

358. Tesavibul N, Dorfman D, Sangwan V, Christen W, Zafirakis P, Rojas B, Foster CS. Costimulatory molecules in ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci 1998;39:982-8.

359. Akpek EK, Kalayci D, Hasitipi A, Foster CS. Behçet’s disease and ocular involovement. Br Med J Turkey 1997;2:11-3.

360. Halpern MT, Palmer CS, Foster CS, Pal A, Battista C. A pharmacoeconomic analysis of rimexolone for the treatment of ophthalmic inflammatory conditions. Am J Managed Care 1998;4:854-62.

361. Merchant A, Zhao T, Foster CS. Chronic keratoconjunctivitis associated with congenital dyskeratosis and erythrokeratodermia variabilis – two rare genodermatoses. Ophthalmology 1998;105:1286-91.

362. Power WJ, Rodriguez A, Pedroza-Seres M, Foster CS. Outcomes in anterior uveitis sssociated with the HLA-B27 haplotype. Ophthalmology 1998;105:1646-51.

363. El-Shabrawi Y, Livir-Rallatos C, Christen W, Foster CS. High levels of IL-12 in the aqueous humor and vitreous of uveitis patients. Ophthalmology 1998;105:1659-63.

364. Nguyen QD, Foster CS. Saving the vision of children with juvenile rheumatoid arthritis-associated uveitis. J Am Med Assoc 1998;280:1133-4.

365. Livir-Rallatos C, El-Shabrawi Y, Zafirakis P, Pellett PE, Stamey FR, Foster CS. Recurrent nodular scleritis associated with varicella zoster virus. Am J Ophthalmol 1998;126:594-7.

366. Foster CS. Ocular manifestations of childhood arthritis. Women’s Health 1998;1:823-33.

367. Messmer EM, Foster CS. Lepromatous uveitis. Graefe’s Arch Clin Exp Ophthalmol 1998;236:717-9.

368. Yang J, Baltatzis S, Foster CS. Peripheral ulcerative keratitis following Salmonella gastroenteritis. Cornea 1998;17:672-4.

369. Sangwan V, Merchant A, Sainz de la Maza, Foster CS. Leukocyte adhesion molecule expression in scleritis. Arch Ophthamol 1998;116:1476-80.

370. Nguyen Q, Foster CS. Ciliary body melanoma masquerading as chronic uveitis. Ocul Immunol Inflamm 1998;6:253-6.

371. Sainz de la Maza, Serra M, Tarrus S, Foster CS. Actitud terapeutica freente a las ulceras corneales no infecciosas asociadas a la artritis reumatolde. Arch Soc Esp Oftalmol 1998;73:477-82.

372. Akpek E, Foster CS. Bilateral acute retinal necrosis caused by cytomegalovirus in an immunocompromized patient. Am J Ophthalmol 1999;127:93-5.

373. Uy H, Nguyen QD, Durand ML, Paton B, Foster CS. Infectious crystalline keratopathy and endophthalmitis secondary to Mycobacterium abscessus in a monocular patient with Stevens-Johnson syndrome. Am J Ophthalmol 1999;127:209-10.

374. Akpek EK, Foster CS. Limbal stem-cell transplantation. Int Ophthalmol Clin 1999;39:71-82.

375. Chan R, Foster CS. A step-wise approach to ocular surface rehabilitation in patients with ocular inflammatory disease. Int Ophthalmol Clin 1999;39:83-108.

376. Nguyen QD, Foster CS. Scleral patch graft in the management of necrotizing scleritis. Int Ophthalmol Clin 1999;39:109-32.

377. Da Mata A, Foster CS. Ahmed valve and uveitic glaucoma. Int Ophthalmol Clin 1999;39:155-68.

378. Uy H, Foster CS. Diagnostic pars plana vitrectomy and uveitis. Int Ophthalmol Clin 1999;39:223-36.

379. Akpek EK, Uy SH, Christen W, Gurdal C, Foster CS. Severity of episcleritis and systemic disease association. Ophthalmology 1999;106:729-31.

380. Akpek EK, Polcharoen W, Foster CS. Conjunctival lymphoma masquerading as chronic conjunctivitis. Ophthalmology 1999;106:757-60.

381. Uy H, Jakobiec F, Pineda R, Shore J, Polcharoen W, Foster CS. Hypertrophic discoid lupus erythematosus of the conjunctiva. Am J Ophthalmol 1999;127:604-5.

382. The Loteprednol Etabonate US Uveitis Study Group. Controlled evaluation of loteprednol etabonate and prednisolone acetate in the treatment of acute anterior uveitis. Am J Ophthalmol 1999;127:537-44.

383. Messmer EM, Foster CS. Vasculitic peripheral ulcerative keratitis. Surv Ophthalmol 1999;43:379-96.

384. Akpek EK, Polcharoen W, Chan R, Foster CS. Ocular surface neoplasia masquerading as chronic blepharoconjunctivitis. Cornea 1999;18:282-8.

385. Foster CS. Ocular manifestations of systemic lupus erythematosus. Women’s Health 1999;2:379-89.

386. Strauss EC, Larson KA, Brenneise I, Foster CS, Larsen GR, Lee MA, Lee JJ. Soluble P-selectin glycoprotein ligand-1 inhibits inflammation in a murine model of allergy. Invest Ophthalmol Vis Sci 1999;40:1336-41.

387. Foster CS, Stavrou P, Zafirakis P, Rojas B, Tesavibul N, Baltatzis S. Intraocular Lens Explantation in Patients with Uveitis. Am J Ophthalmol 1999;128:31-7.

388. Akpek EK, Ahmed I, Jakobiec FA, Hochberg HF, Sohelian M, Foster CS. Intraocular-central nervous system lymphoma: Clinical features, diagnosis and outcomes. Ophthalmology 1999;106:1805-10.

389. Chan RY, Bhol K, Tesavibul N, Letko E, Simmons RK, Foster CS, Ahmed AR. The role of antibody to human ?4 integrin in conjunctival basement membrane separation: possible in vitro model for ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci 1999;40:2283.

390. Merayo-Lloves J, Power WJ, Rodriguez A, Pedroza M, Baltatzis S, Foster CS. Secondary glaucoma in patients with uveitis. Ophthalmologica 1999;213:300-4.

391. Letko E, Bhol K, Pinar V, Foster CS, Ahmed R. Tacrolimus (FK 506). Ann Allergy Asthma Immunol 1999;83:179-89.

392. Foster CS, Ahmed R. Intravenous immunoglobulin therapy for ocular cicatricial pemphigoid. Ophthalmology 1999;106:2136-43.

393. Da Mata A, Burk SE, Netland PA, Baltatzis S, Christen W, Foster CS. Management of uveitic glaucoma with Ahmed glaucoma valve implantation. Ophthalmology 1999;106:2168-72.

394. Akpek EK, Maca S, Christen WG, Foster CS. Elevated vitreal interleukin-10 level is not diagnostic of intraocular-CNS lymphoma. Ophthalmology 1999;106:2291-5.

395. Sangwan V, Akpek AK, Voo I, Zhao TZ, Pinar V, Yang J, Christen W, Baltatzis S, Foster CS. Krill protease effects on wound healing following corneal alkali burn. Cornea 1999;18:707-11.

396. Foster CS, Samson CM. Peripheral corneal ulcer. Canadian Ophthalmic Case Consultations 1999;3:5-6.

397. Hu S, Dutt J, Arrunategui-Correa, Baltatzis S, Foster CS. Cytokine mRNA expression in BALB/c mouse corneas infected with herpes simplex virus. Eye 1999;13:309-13.

398. Rojas B, Zafirakis P, Christen W, Markomichelakis NN, Foster CS. Medical treatment of macular edema in patients with uveitis. Doc Ophthalmol 1999;97:399-407.

399. Arrunategui-Correa V, Baltatzis S, Foster CS. The role of cytokines in experimental herpes simplex keratitis. Acta Virologica 1999;43:325-30.

400. Samson CM, Foster CS. Chronic postoperative endophthalmitis. Int Ophthalmol Clin 2000;40:57-68.

401. Gasch AT, Foster CS, Grosskreutz CL, Pasquale LR. Postoperative sympathetic ophthalmia. Int Ophthalmol Clin 2000;40:69-84.

402. Harper SL, Foster CS. Intraocular lens explantation in uveitis. Int Ophthalmol Clin 2000;40:107-16.

403. Gion N, Stavrou P, Foster CS. Immunomodulatory therapy for chronic tubulointerstitial nephritis associated uveitis (TINU). Am J Ophthalmol 2000;129:764-8.

404. Foster CS. Discussion: Shimazaki et al. – Ocular surface reconstruction for Stevens-Johnson syndrome. Ophthalmology 2000;107:1523.

405. Letko E, Bhol K, Foster CS, Ahmed AR. Linear IgA bullous disease (LABD) limited to the eye. Ophthalmology 2000;107:1524-8.

406. El-Shabrawi Y, Foster CS. Correlation of metalloproteinase –2 and –9 with proinflammatory cytokines interleukin-1?, interleukin-12 and the interleukin-1 receptor sntagonist in patients with chronic uveitis. Curr Eye Res 2000;20:211-4.

407. Bhol KC, Simmons RK, Dans MJ, Foster CS, Giancotti FG, Ahmed AR. The autoantibodies to alpha 6 beta 4 integrin of patients affected by ocular cicatricial pemphigoid recognize predominantly epitopes within the large cytoplasmic domain of human beta 4. J Immunol 2000;165:2824-9.

408. Romero-Rangel T, Stavrou P, Cotter J, Rosenthal P, Baltatzis S, Foster CS. Gas-permeable scleral contact lens therapy in ocular surface diseases. Am J Ophthalmol 2000;130:25-32.

409. Foster CS, Havrlikova K, Tugal-Tutkun I, Merayo-Lloves J, Christen W. Secondary glaucoma in patients with juvenile rheumatoid arthritis-associated iridocyclitis. Acta Ophthalmologica 2000;78:576-9.

410. Jabs DA, Rosenbaum JT, Foster CS, Holland GN, Jaffe GJ, Louie JS, Nussenblatt RB, Stiehm ER, Tessler H, Van Gelder RN, Whitcup SM, Yocum D. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol 2000;130:492-513.

411. Foster CS. American Uveitis Society Meeting Summary October 1999. Oc Immunol Inflamm 2000;8.

412. Letko E, Bhol K, Foster CS, Ahmed AR. Influence of intravenous immunoglobulin therapy on serum levels of anti-ß4 antibodies in ocular cicatricial pemphigoid: A correlation with disease activity. Curr Eye Res 2000;21: 646-54.

413. Akpek EK, Foster CS. Primary intraocular lymphoma with a low interleukin-10 to interleukin-6 ratio and heterogenous IgH gene arrangement. Arch Ophthalmol 2000;118:731.

414. Nguyen QD, Uy HS, Akpek EM, Harper S, Zacks D, Foster CS. Choroidopathy in systemic lupus erythematosus. Lupus 2000;9:288-98.

415. Perez VL, Foster CS. Uveitis with neurological manifestations. Int Ophthalmol Clin 2001;41:41-59.

416. Kumari S, Bhol KC, Simmons RK, Razzaque MS, Letko E, Foster CS. Identification of ocular cicatricial pemphigoid antibody binding site(s) in human ?4 integrin. Invest Ophthalmol Vis Sci 2001;42:379-85.

417. Miserocchi E, Baltatzis S, Foster CS. Ocular features associated with anticardiolipin antibodies: A descriptive study. Am J Ophthalmol 2001;131:451-6.

418. Nouri M, Terada H, Alfonso EC, Foster CS, Durand ML, Dohlman CH. Endophthalmitis after keratoprosthesis. Incidence, bacterial causes and risk factors. Arch Ophthalmol 2001;119:484-9.

419. Uy H, Nguyen QD, Arbour J, Gravel M, D’Amico DJ, Jakobiec FA, Foster CS. Sclerosing inflammatory pseudotumor of the eye. A case report. Arch Ophthalmol 2001;119:603-7.

420. Miserocchi E, Foster CS. Cheratite da herpes simplex virus. Riv Trime Oftalomol 2001;2:5-10.

421. Letko E, Stechschulte S, Kenyon KR, Sadeq N, Romero TR, Samson CM, Nguyen QD, Harper SL, Primack JD, Azar DT, Gruterich M, Dohlman CD, Baltatzis S, Foster CS. Amniotic membrane inlay and overlay grafting for corneal epithelial defects and stromal ulcers. Arch Ophthalmol 2001;119:659-63.

422. Akpek EK, Foster CS. Interleukin-10 and intraocular-central nervous system lymphoma – Author’s reply. Ophthalmology 2001;108:426-7.

423. Foster CS. The Conrad Berens Lecture: Chronic cicatricial conjunctivitis. J Contact Lens Assoc Ophthalmol 2001;27:61-7l.

424. Miserocchi E, Baltatzis S, Foster CS. A case of atypical Cogan’s syndrome with uncommon corneal findings. Cornea 2001;20:540-2.

425. Ocampo VVD, Foster CS, Baltatzis S. Surgical excision of iris nodules in the management of sarcoid uveitis. Ophthalmology 2001;108:1296-9.

426. Sippel KC, Ma JJK, Foster CS. Amniotic membrane surgery. Curr Opin Ophthalmol 2001;12:269-81.

427. Meldrum ML, Kurban RS, Foster CS, Albert DM, O’Brien JM. Collagen vascular diseases: cutaneous manifestations in ophthalmology. Ophthal Plas Recon Surg 2000;16:459-70.

428. Harper SL, Letko E, Samson CM, Zafirakis P, Sangwan V, Nguyen QD, Uy H, Baltatzis S, Foster CS. Wegener’s granulomatosis: The relationship between ocular and systemic disease. J Rheumatol 2001;28:1025-32.

429. Foster CS. Immunomdulatory therapy for chronic tubulointerstitial nephritis-associated uveitis – Author’s reply. Am J Ophthalmol 2001;132:447.

430. Samson CM, Waheed NK, Baltatzis S, Foster CS. Methotrexate treatment of uveitis. Ophthalmology 2001;108:1134-9.

431. Nguyen Q, Uy HS, Merchant A, Medina C, Zhao T, Zhao Z, Cantor H, Baltatzis S, Foster CS. Fas-fas ligand and HSV uveitis and keratitis. Invest Ophthalmol Vis Sci 2001;42:2505-9.

432. Afshari NA, Afshari MA, Foster CS. Inflammatory conditions of the eye associated with rheumatic diseases. Curr Rheumatol Rep 2001;3:453-63.

433. Sami N, Bhol KC, Beutner EH, Plunkett RW, Leiferman KM, Foster CS, Ahmed AR. Simultaneous presence of mucous membrane pemphigoid and pemphigus vulgaris: molecular characterization of both autoantibodies. Clin Immunol 2001;100: 219-27.

434. Samson CM, Ekong A, Foster CS. Uveitis in children: diagnosis and management. Int Ophthalmol Clin 2001;41:199-216.

435. Yao L, Foster CS. Tubulointerstitial nephritis and uveitis syndrome. Int Ophthalmol Clin 2001;41:217-32.

436. Waheed NK, Miserocchi E, Foster CS. Ocular concerns in juvenile rheumatoid srthritis. Int Ophthalmol Clin 2001;41:223-34.

437. Sainz de la Maza Serra M, Escobar Barranco JL, Foster CS. [Characteristics of scleritis in patients older than 60 years]. Arch Soc Esp Oftalmol 2001;76:425-30.

438. Kumari S, Bhol KC, Rehman F, Colon J, Foster CS, Ahmed AR. Interleukin-1 components in ocular cicatricial pemphigoid. Role in intravenous immunoglobulin therapy. Cytokine 2001;14:218-24.

439. Letko E, Ahmed AR, Foster CS. Treatment of ocular cicatricial pemphigoid with tacrolimus (FK506). Graefes Arch Clin Exp Ophthalmol 2001;239:441-4.

440. Razzaque MS, Foster CS, Ahmed AR. Tissue and molecular events in human conjunctival scarring in ocular cicatricial pemphigoid. Histol Histopathol 2001;16:1203-12.

441. Chan R, Yannuzzi LA, Foster CS. Ocular Whipple’s disease: Earlier effective diagnosis Ophthalmol 2001;108:2225-31.

442. Stavrou P, S Baltatzis, Letko E, Samson CM, Christen W, Foster CS. Pars plana vitrectomy in patients with intermediate uveitis. Ocul Immunol Inflamm 2001;9:141-52.

443. Akpek EK, Baltatzis S, Yang J, Foster CS. Long-term immunosuppressive treatment in serpiginous choroiditis. Ocul Immunol Inflamm 2001;9:153-68.

444. Uy H, Christen W, Foster CS. HLA-B27 associated uveitis and macular edema. Ocul Immunol Inflamm 2001;9:177-84.

445. Merayo-Lloves J, Baltatzis S, Foster CS. Epstein-Barr virus dacryoadenitis resulting in keratoconjunctivitis sicca in a child: diagnosis and treatment. Am J Ophthalmol 2001;132:922-3.

446. Miserocchi E, Waheed NK, Baltatzis S, Foster CS. Chronic cicatrizing conjunctivitis in a patient with ocular cicatricial pemphigoid and fatal Wegener’s granulomatosis. Am J Ophthalmol 2001;132:923-4.

447. Sainz de la Maza M, Foster CS, Jabbur NS, Baltatzis S. Ocular characteristics and disease associations in scleritis-associated peripheral keratopathy. Arch Ophthalmol 2002;120:15-9.

448. Miserocchi E, Baltatzis S, Roque MR, Ahmed AR, Foster CS. The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid. Ophthalmology 2002;109:111-8.

449. Miserocchi E, Baltatzis S, Ekong A, Roque MR, Foster CS. The efficacy and safety of chlorambucil in intractable non-infectious uveitis. The Massachusetts Eye and Ear Infirmary experience. Ophthalmology 2002;109:137-42.

450. Ekong A, Foster CS, Roque M. Eye involvement in autoimmune blistering disease. Clin Dermatol 2001;19:742-9

451. Michel SS, Ekong A, Baltatzis S, Foster CS. Multifocal choroiditis and panuveitis (MCP): Immunomodulatory therapy. Ophthalmology 2002;109:378-83.

452. Chan LS, Ahmed AR, Anhalt GJ, Bernauer W, Cooper KD, Elder MJ, Fine JD, Foster CS, Ghohestani R, Hashimoto T, Hoang-Xuan T, Kirtschig G, Korman NJ, Lightman S, Lozada-Nur F, Marinkovich MP, Mondino BJ, Prost C, Rogers RS. The first international concensus on mucous membrane pemphigoid: Definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic factors. Arch Dermatol 2002;138:370-9.

453. Foster CS. Understanding mast cell heterogeneity. Rev Ophthalmol 2002;9:86-7.

454. Abelson M, Foster CS, Gupta G. Diagnosing and managing anterior uveitis. Rev Ophthalmol 2002;110-4.

455. Foster CS. Book Review – Drug-Induced Ocular Side Effects, 5th Edition (Frauenfelder FT, Frauenfelder FW). Arch Ophthalmol 2002;120:1002.

456. Foster CS, Papadaki TG. Diagnostic evaluations to guide therapy for anterior uveitis. Contemp Opthalmol 2002;1:1-8.

457. Samson CM, Nduaguba C, Baltatzis S, Foster CS. Limbal stem cell transplantation in chronic inflammatory eye disease. Ophthalmology 2002;109:862-8.

458. Akpek EK, Jabs DA, Tessler HH, Joondeph BC, Foster CS. Successful treatment of serpiginous choroiditis with alkylating agents. Ophthalmology 2002;109:1506-13.

459. Miserocchi E, Waheed NK, Dios E, Christen W, Merayo-Lloves J, Roque M, Foster CS. Visual outcomes in HSV and VZV uveitis: A clinical evaluation and comparison. Ophthalmology 2002;109:1532-7.

460. Razzaque MS, Foster CS, Ahmed AR. Role of enhanced expression of m-CSF in conjunctiva affected by cicatricial pemphigoid is associated with increased accumulation of macrophages. Invest Ophthalmol Vis Sci 2002;43:2977-83.

461. Letko E, Zafirakis P, Baltatzis S, Voudouri A, Livir-Rallatos C, Foster CS. Relapsing polychondritis – A clinical review. Semin Arthritis Rheum 2002;31:384-95.

462. Zacks DM, Samson CM, Loewenstein J, Foster CS. Electroretinograms as an indicator of disease activity in birdshot retinochoroidopathy. Graefes Arch Clin Exp Ophthalmol 2002;240:601-7.

463. Letko E, Bhol K, Colon J, Foster CS, Ahmed AR. Biology of interleukin-5 in ocular cicatricial pemphigoid. Graefes Arch Clin Exp Ophthalmol 2002;240:565-9.

464. Chu DS, Foster CS. Sympathetic ophthalmia. Int Ophthalmol Clin 2002;42:179-85.

465. Strauss EC, Foster CS. Atopic ocular disease. Ophthalmol Clin North Am 2002;15:1-5.

466. Miserocchi E, Modorati G, Foster CS, Brancato R. Ocular and extracutaneous involvement in Pyoderma gangrenosum. Ophthalmology 2002;109:1941-3.

467. Miserocchi E, Baltatzis S, Roque MR, Ahmed AR, Foster CS. The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid. NY Sight – NY State Ophthalmologic Society 2002;Summer:28-35.

468. Alio JL, Chipont E, BenEzra D, Fakhry MA, Foster CS, Baarsma GS, Beekhuis WH, Ohno S, Burtin T, Belfort R, Muccioli C, Uusitalo R, Juhas R, Garcia PH, Attia HE, Shalash R, Sainz de la Maza M. Comparative performance of intraocular lenses in eyes with cataract and uveitis. J Cataract Refract Surg 2002;28:2096-108.

469. Perez VL, Azar DT, Foster CS. Sterile corneal melting and necrotizing scleritis after cataract surgery in patients with rheumatoid arthritis and collagen vascular disease. Semin Ophthalmol 2002;17:124-30.

470. Yu EN, Foster CS. Chronic post-operative endophthalmitis due to Pseudomonas oryzihabitans. Am J Ophthalmol 2002;134:613-4.

471. Foster CS. Ocular Whipple’s disease. Ophthalmology 2002;109:1952-3.

472. Papaliodis GN, Nguyen QD, Samson CM, Foster CS. Intraocular lens tolerance in surgery for cataracta complicata: Assessment of four implant materials. Semin Ophthalmol 2002;17:120-3.

473. Levinson RD, Park MS, Rikkers SM, Reed EF, Smith JR, Martin TM, Rosenbaum JT, Foster CS, Sherman MD, Holland GN. Strong associations between specific HLA-DQ and HLA-DR alleles and the tubulointerstitial nephritis and uveitis syndrome. Invest Ophthalmol Vis Sci 2003;44:653-7.

474. Baltatzis S, Romero-Rangel T, Foster CS. Sectorial keratitis and uveitis: differential diagnosis. Graefes Arch Clin Exp Ophthalmol 2003;241:2-7.

475. Batchelor TT, Del Checcolol G, Ciordial R, Foster CS, Henson JW. High-dose methotrexate for intraocular lymphoma. Clin Cancer Res 2003;9:711-5.

476. Argüeso P, Tisdale A, Mandel U, Letko E, Foster CS, Gipson IK. The cell-layer – and cell-type – specific distribution of GalNAc-transferase in the ocular surface epithelia is altered during keratinization. Invest Ophthalmol Vis Sci 2003;44:86-92.

477. Foster CS, Rashid S. Management of coincident cataract and uveitis. Curr Opin Ophthalmol 2003;14:1-6.

478. Foster CS, Tufail F, Waheed NK, Chu D, Miserocchi E, Baltatzis S, Vredeveld CM. Efficacy of etanercept in preventing relapse of uveitis controlled by methotrexate. Arch Ophthalmol 2003;121:437-40.

479. Papaliodis GN, Chu DS, Foster CS. Treatment of ocular inflammatory disorders with daclizumab. Ophthalmology 2003;110:786-9.

480. Razzaque MS, Foster CS, Ahmed AR. Role of collagen-binding heat shock protein 47 in ocular cicatricial pemphigoid conjunctival scarring. Invest Ophthalmol Vis Sci 2003;44:1616-21.

481. Razzaque MS, Foster CS, Ahmed AR. Role of connective tissue growth factor in the pathogenesis of conjunctival scarring in ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci 2003;44:1998-2003.

482. Thakker MM, Perez VL, Moulin A, Cremers SL, Foster CS. Multifocal nodular episcleritis and scleritis in a patient with undiagnosed Hodgkin’s lymphoma. Ophthalmology 2003;110:1057-60.

483. Baltatzis S, Tufail F, Yu EN, Vredeveld CM, Foster CS. Mycophenolate mofetil as an immunodulatory agent in the treatment of chronic ocular inflammatory disorders. Ophthalmology 2003;110:1061-5.

484. Stavrou P, Tufail F, Baltatzis S, Foster CS. Immunomodulatory treatment in patients with severe sympathetic ophthalmia. Middle East J Ophthalmol 2003;10:73-6.

485. Miserocchi E, Modorati G, Azzolini C, Foster CS, Brancato R. Herpes simplex virus type 2 acute retinal necrosis in an immunocompetent patient. Eur J Ophthalmol 2003;13:99-102.

486. Cunha RNP, Campos M, Dulley FL, Rojas B, Foster CS. Dry eye evaluation and immunohistochemical study of the conjunctiva and lacrimal gland of bone marrow transplantation patients. Arquivos Brasileiros de Oftalmologia 2003.

487. Trocme SD, Leiferman KM, George T, Bonini S, Foster CS, Smit EE, Sra SK, Grabowski WR, Dohlman CH. Neutrophil and eosinophil participation in atopic and vernal keratoconjunctivitis. Curr Eye Res 2003;26:319-25.

488. Razzaque MS, Kumari S, Foster CS, Ahmed AR. Expression profiles of collagens, HSP47, TGF-beta1, MMPs and TIMPs in epidermolysis bullosa acquisita. Cytokine 2003;21:207-13.

489. Razzaque MS, Ahmed BS, Foster CS, Ahmed AR. Effects of IL-4 on conjunctival fibroblasts: possible role in ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci 2003;44:3417-23.

490. Ahmed AR, Dahl MV, Consensus Development Group. Consensus statement on the use of intravenous immunoglobulin therapy in the treatment of autoimmune mucocutaneous blistering diseases. Arch Dermatol 2003;139:1051-9.

491. Kiss S, Letko E, Qamruddin S, Baltatzis S, Foster CS. Long-term progression, prognosis and treatment of patients with recurrent ocular manifestations of Reiter’s syndrome. Ophthalmology 2003;110:1764-9.

492. Yao L, Baltatzis S, Zafirakis P, Livir-Rallatos C, Voudouri A, Markomichelakis N, Zhao T, Foster CS. Human mast cell subtypes in conjunctiva of patients with atopic keratoconjunctivitis, ocular cicatricial pemphigoid and Stevens-Johnson syndrome. Ocul Immunol Inflamm 2003;11:211-22.

493. Androudi S, Brazitikos P, Iaccheri B, Fiore T, Christen W, Meniconi M, Foster CS. Outcomes of early and late immunomodulatory treatment in patients with HLA-B27-associated chronic uveitis. Graefes Arch Clin Exp Ophthalmol 2003;241:1000-5.

494. Foster CS. Diagnosis and treatment of juvenile idiopathic arthritis-associated uveitis. Curr Opin Ophthalmol 2003;14:395-8.

495. Androudi S, Iaccheri B, Brazitikos P, Papadaki T, Foster CS. Bilateral chronic anterior uveitis & neuroophthalmologic manifestations in a patient with Churg-Strauss syndrome: an unusual ocular presentation. Ocul Immunol Inflamm 2004;12:59-63.

496. Razzaque MS, Foster CS, Ahmed AR. Role of macrophage migration inhibitory factor in conjunctival pathology in ciciatricial pemphigoid. Invest Ophthalmol Vis Sci 2004;45:1174-81.

497. Durrani K, Papaliodis G, Foster, CS. Pulse IV Cyclophosphamide in Ocular Inflammatory Disease. Ophthalmology 2004;111(5):960-5.

498. Durrani K, Hynes A, Foster CS. The White Dot Syndromes. Contemporary Ophthalmology 2004 Pt I & II; 3(6):1-7, (7):1-6

499. Holland GN, Stiehm ER, Additional participants in the workshop “Evaluation . Special Considerations in the Evaluation and management of Uveitis in Children. Am J Ophthalmology 2003;135(6):867-78

500. Kump L, Paredes I, Foster CS. Treatment of ocular toxoplasmosis in pregnancy. Philippine Journal of Ophthalmology 2004;29(2): 88-93

501. Markomichelakis N, Chatzisefanou K, Dafni U, Christen WG, Zafirakis P, Rojas B, Foster CS. Characteristics of Systemic Disease-Associated and Idiopathic Arthritis-associated Uveitis. Middle East Journal of Ophthalmology 2004;12(1):5-12

502. Stavrou P, Yu EN, Baltatzis S, Gion N, Zein G, Foster CS. Cataract Surgey in Patients with Scleritis. Middle East Journal of Ophthalmology 2004;12(1):13-17

503. Papadaki T, Papaliodis G, Zacharopoulos I, Christen W, Soheilian M, Foster CS. Infectious Uveitis and the Role of Diagnostic Vitrectomy. Middle East Journal of Ophthalmology 2004;12(1):33-39

504. Stavrou P, Yu E, Baltatzis S, Foster CS. Par Plana Vitrectomy in Juvenile Idiopathic Arthritis-Associated Uveitis. Middle East Journal of Ophthalmology 2004;12:2:117-121.

505. Daoud YJ, Letko E, Nguyen QD, Soukiasian SH, Samson CM, Sangwan V, Harper SL, Michel S, Schuman JS, Foster CS. Aqueous humour outflow facility in OCP. Middle East Journal of Ophthalmology 2004;12:102-107

506. Markomichelakis NN, Iaccheri B, Fiore T, Chatzistefanou KI, Dafni U, Christen W, Rojas B, Sohelian M, Baltatzis S, Foster CS. Intermediate uveitis: prognostic factors and course of disease. Middle East Journal of Ophthalmology 2004;12:2:83-88

507. Letko E, Miserocchi E, Daoud YJ, Christen W, Foster CS, Ahmed AR. A nonrandomized comparison of the clinical outcome of ocular involvement in patients with mucous membrane (cicatricial) pemphigoid between conventional immunosuppressive and intravenous immunoglobulin therapies. Clin Immunol. 2004 ;111(3):303-10.

508. Vavvas D, Foster CS. Immunomodulatory Medications in Uveitis. International Ophthalmology Clinics 2004;4(3): 187-203.

509. Perez V, Chavala S, Ahmed M, Chu D, Zafirakis P, Baltatzis S, Ocampo V, Foster CS. Ocular Manifestations and Concepts of Systemic Vasculitudes. Survey of Ophthalmology 2004;49(4):399-418.

510. Sami N, Letko E, Androudi S, Foster CS, Ahmed AR. Intravenous immunoglobulin therapy in patients with ocular cicatricial pemphigoid: A long-term follow-up. Ophthalmology 2004;111(7):1380-2.

511. Cervantes RA, Kump LI, Foster CS. Glucocorticoid-induced osteoporosis: considerations in ophthalmology. Ophthalmology 2004;111(8):1437-8

512. El Shabrawi Y, Walch A, Hermann J, Egger G, Foster CS. Inhibition of MMP –dependent Chemotaxis and Amelioration of Experimental Autoimmune Uveitis with a Selective Metalloproteinase-2 and -9 Inhibitor. J Neuroimmunol. 2004 155: 13-20

513. Foster CS, Sainz De La Maza M. Ocular cicatricial pemphigoid review. Curr Opin Allergy Clin Immunol. 2004 Oct;4(5):435-9.

514. Perez VL, Papaliodis GN, Chu D, Christen W, Foster CS. Elevated IL-6 in the vitreous fluid of patients with pars planitis and posterior uveitis. Ocular Immunology Inflammation. 2004;12(3):205-14

515. Ahmed M, Zein G, Khawaja F, Foster CS. Ocular Cicatrial Pemphigoid: Pathogenesis, Diagnosis and Treatment. Progress in Retinal & Eye Research 2004;23:579-592

516. Thadani SM, Foster CS . Treatment of ocular inflammation in children. Paediatr Drugs. 2004;6(5):289-301

517. Havrlikova K, Mellott M, Kaufman AH, Loredo GA, Peters JH, Colvin RB, Foster CS. Expression of fibronectin isoforms bearing the alternatively spliced EIIB, and V segments in corneal alkali burn and keratectomy wound models in the Rat. Cornea 2004 ;23(8):812-8.

518. Iaccheri B, Roque M, Fiore T, Papadaki T, Mathew B, Baltatzis S, Emara B, Tokarewicz AC, Foster CS. Ocular Cicatricial Pemphigoid, Keratomycosis and Intravenous Immunoglobulin Therapy. Cornea. 2004;23(8):819-22.

519. Zein G, Berta A, Foster CS. Multiple sclerosis associated uveitis. Ocular Immunology Inflammation 2004;12(2): 137-42

520. Ahmed M, Androudi S, Brazitikos P, Paredes I, Foster CS. 360 degrees iris-ciliary body B-cell lymphoma masquerading as post-cataract uveitis. Semin Ophthalmol. 2004 Sep-Dec;19(3-4):127-9.

521. Rubin PA, Foster CS. Etiology and management of idiopathic orbital inflammation. Am J Ophthalmol. 2004;138(6):1041-3.

522. Topalkara A, Ahmed M, Foster CS. Highlights of Modern Diagnosis in Uveitis – Part 2: Useful imaging and Molecular Diagnostic Studies. Highlights of Ophthalmology, 2005, 33:2: 17-19

523. Durrani K, Foster CS. Psoriatic Uveitis: A Distinct Clinical Entity? Am J Ophthalmol. 2005;139(1):106-11.

524. Androudi S, Foster CS. Valsalva retinopathy. Diagnostic Challenges in a Patient with Pars-Planitis. Acta Ophthalmologica. 2005.83: 256-257

525. Androudi S, Ahmed M, Foster CS. Combined pars plana vitrectomy and phacoemulsification to restore visual acuity in patients with chronic uveitis. J Cataract Refract Surg. 2005;31(3):472-8

526. Letko E, Papaliodis DN, Papaliodis GN, Daoud YJ, Ahmed AR, Foster CS. Stevens-Johnson syndrome and toxic epidermal necrolysis: A Review of the literature. Ann Allergy Asthma Immunol. 2005;94(4):419-36

527. Acharya N, Pineda R 2nd, Uy HS, Foster CS. Discoid lupus erythematosus masquerading as chronic blepharoconjunctivitis. Ophthalmology. 2005;112(5):e19-23.

528. Nussenblatt RB, Peterson JS, Foster CS, Rao NA, See RF, Letko E, Buggage RR. Initial evaluation of subcutaneous daclizumab treatments for noninfectious uveitis: a multicenter noncomparative interventional case series. Ophthalmology. 2005;112:764-70.

529. Kathiresan S, Kelsey PB, Steere AC, Foster CS, Curvelo MS, Stone JR. Case records of the Massachusetts General Hospital. Case 14-2005. A 38-year-old man with fever and blurred vision. N Engl J Med. 2005;12;352:2003-12.

530. Kump LI, Cervantes-Castaneda RA, Androudi SN, Foster CS. Analysis of pediatric uveitis cases at a tertiary referral center. Ophthalmology. 2005;112(7):1287-92.

531. Kiss S, Ahmed M, Letko E, Foster CS. Long-term Follow-up of Patients with Birdshot Retinochoroidopathy Treated with Corticosteroid-Sparing Systemic Immunomodulatroy Therapy. Ophthalmol. 2005. 112:1066-1071

532. Baehring JM, Androudi S, Longtine JJ, Betensky RA, Sklar J, Foster CS, Hochberg FH. Analysis of clonal immunoglobulin heavy chain rearrangements in ocular lymphoma. Cancer. 2005;104(3):591-7.

533. Androudi S, Letko E, Meniconi M, Papadaki T, Ahmed M, Foster CS. Safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edema. . Ocul Immunol Inflamm. 2005;13:205-12

534. Kafkala C, Hynes A, Choi J, Topalkara A, Foster CS. Ahmed valve implantation for uncontrolled pediatric uveitic glaucoma. J AAPOS. 2005;9(4):336-40.

535. Rojas B, Cuhna R, Zafirakis P, Ramirez JM, Lizan-Garcii A M, Zhao T, Foster CS. Cell populations and adhesion molecules expression in conjunctiva before and after bone marrow transplantation. Exp Eye Res. 2005;81(3):313-325.

536. Lima Cabrita FV, Foster CS. Anticardiolipin antibodies and ocular disease.
Ocul Immunol Inflamm. 2005;13:265-70.

537. Eschle-Meniconi ME, Ahmad SR, Foster CS. Mucous membrane pemphigoid: an update.
Curr Opin Ophthalmol. 2005 Oct;16(5):303-7

538. Kump LI, Androudi SN, Foster C. Ocular toxoplasmosis in pregnancy. Clin Experiment Ophthalmol. 2005;33:455-60.

539. Paredes I, Ahmed M, Foster CS. Diagnostic Evaluations to Guide Therapy for Adamantiades-Behçet’s Disease. Contemporary Ophthalmology 2005;4;1:1-8

540. Daoud YJ, Cervantes R, Foster CS, Ahmed AR. Ocular pemphigus. J Am Acad Dermatol. 2005 Oct;53(4):585-90.

541. Hynes AY, Kafkala C, Daoud YJ, Foster CS. Controversy in the use of high-dose systemic steroids in the acute care of patients with stevens-johnson syndrome. Int Ophthalmol Clin. 2005;45(4):25-48.

542. Jabs DA, Nussenblatt RB, Rosenbaum JT; Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005 Sep;140(3):509-16.

543. Rashid S, Foster CS. Intermediate Uveitis. Contemporary Ophthalmology 2005:4:8:1-8

544. Hatton MP, Rubin PA, Foster CS. Successful treatment of idiopathic orbital inflammation with mycophenolate mofetil. Am J Ophthalmol. 2005 Nov;140(5):916-8.

545. Choopong P, Khan N, Sangwan VS, Zafirakis P, Rallatos CL, Rojas B, Baltatzis S, Foster CS. Eosinophil activation in Wegener's granulomatosis: a harbinger of disease progression? Ocul Immunol Inflamm. 2005 Dec;13(6):439-45.

546. Papadaki T, Zacharopoulos I, Iaccheri B, Fiore T, Foster CS. Somatostatin for Uveitic Cystoid Macular Edema (CME). Ocul Immunol Inflamm. 2005 Dec;13(6):469-70.

547. Kafkala C, Daoud YJ, Paredes I, Foster CS. Masquerade scleritis. Ocul Immunol Inflamm. 2005 Dec;13(6):479-82

548. Yu EN, Meniconi ME, Tufail F, Baltatzis S, Foster CS. Outcomes of treatment with immunomodulatory therapy in patients with corticosteroid-resistant juvenile idiopathic arthritis-associated chronic iridocyclitis. Ocul Immunol Inflamm. 2005 Sep-Oct;13(5):353-60.

549. Daoud YJ, Foster CS, Ahmed R. Eyelid skin involvement in pemphigus foliaceus. Ocul Immunol Inflamm. 2005 Sep-Oct;13(5):389-94.

550. Klisovic DD, Foster CS.Microscopic Polyangiitis and ocular disease. Contemporary Opthalmology 2006;5:2:1-8

551. Onal S, Foster CS. Retinal vasculitis. Contemporary Opthalmology 2006;5:3:1-8

552. Sobrin L, Foster CS. Systemic lupus erythematosus. Contemporary Opthalmology 2006;5:4:1-8

553. Cordero M, Sobrin L, Foster CS. Sympathetic Ophthalmia. Contemporary Opthalmology 2006;5:5:1-8

554. Anzaar F, Foster CS. Giant Cell Arteritis. Contemporary Ophthalmology 2006;5:6:1-8

555. Paredes I, Ahmed M, Foster CS. Immunomodulatory therapy for vogt-koyanagi-harada patients as first-line therapy. Ocul Immunol Inflamm. 2006 Apr;14(2):87-90.

556. Kump LI, Cervantes-Castaneda RA, Androudi SN, Foster CS, Christen WG. Patterns of exacerbations of chronic non-infectious uveitis in pregnancy and puerperium. Ocul Immunol Inflamm. 2006 Apr;14(2):99-104.

557. Teasley LA, Foster CS. Primary Intraocular Lymphoma : Update on Diagnosis and Treatment. Contemporary Ophthalmology 2006;5:7:1-6

558. Gamm DM, Harris A, Mehran RJ, Wood M, Foster CS, Mootha VV. Mucous Membrane Pemphigoid With Fatal Bronchial Involvement in a Seventeen-Year-Old Girl.Cornea. 2006 May;25(4):474-478.

559. Foster CS. Uveitis:Serious cause of visual loss in children. Rev Ophthalmol May 2006; 36-40

560. Jaffe GJ, Martin D, Callanan D, Pearson A, Leby B, Comstock T & Fluocinolone Acetonide Uveits Study Group. Fluocinolone Acetonide Implant (Retisert) for Noninfectious Posterior Uveitis: theirty four week results of amulticenter randomized clinical study. Ophthalmology 2006;113;6:1020-1027

561. Klisovic DD, Foster CS. Adamantiades-Behcet Disease. Contemporary Ophthalmology 2006; 5:10:1-8

562. Ceron O, Foster CS. Practical Guide to the Interpretation of Fluorescein
Angiography. Contemporary Ophthalmology 2006; 5:11:1-10

563. Kiss S, Anzaar F, Foster CS. Birdshot Retinochoroidopathy. Int Ophth Clin 2006;46:2:39-55

564. Andreoli CM, Foster CS. Vogt-Koyanagi-Harada Disease. Int Ophth Clin 2006;46:2:111-122

565. Hong JE, Foster CS. Spirochetal Uveitis. Int Ophth Clin 2006;46:2:123-139

566. Kim, EC, Foster CS. Immunomodulatory Therapy for the Treatment of Ocular Inflammatory Disease: Evidence-based Medicine Recommendations for Use. Int Ophth Clin 2006;46:2:141-164

567. Yu EN, Jurkunas U, Rubin PA, Baltatzis S, Foster CS. Obliterative Microangiopathy Presenting as Chronic Conjunctivitis in a Patient With Relapsing Polychondritis. Cornea. 2006 Jun;25(5):621-622.

568. Kump LI, Castaneda RA, Androudi SN, Reed GF, Foster CS. Visual Outcomes in Children with Juvenile Idiopathic Arthritis-Associated Uveitis. Ophthalmology. 2006 ;

569. Choi JY, Kafkala C, Foster CS. Primary intraocular lymphoma: a review. Semin Ophthalmol. 2006;21(3):125-33.

570. Khan N, Huang JJ, Foster CS. Cancer Associated Retinopathy (CAR): An Autoimmune-Mediated Paraneoplastic Syndrome. Semin Ophthalmol. 2006;21(3):135-41.

571. Ahmed M, Foster CS. Steroid Therapy for Ocular Inflammatory Disease. Focal Points, American Academy of Ophthalmology 2006; 24:7:1-13

572. Foster CS. Cataract Surgery and Uveitis. Current Insight, American Academy of Ophthalmology, Summer 2006;
573. Kafkala C, Choi JY, Choopong P, Foster CS. Octreotide as a Treatment for Uveitic Cystoid Macular Edema. Arch Ophthalmol 2006;124(9):1353-5.
574. Ocampo J, Yu E, Zhao TZ, Feroze K, Foster CS. Toxicity of 0.2% Chlorhexidine Gluconate to the Cornea and Adjacent Structures. Philippine Journal of Ophthalmology, 2006; 30(3): 119-123.
575. Fortuna ES, Hinkle D, Foster CS. Management of anterior uveitis: Immunomodulatory Therapy is gaining acceptance. Ophthalmology Management 2006;October; 61-101
576. Papadaki TG, Kafkala C, Zacharopoulos IP, Seyedahmadi B J, Dryja T, Foster CS. Conjunctival Non-Caseating Granulomas in a Human Immunodeficiency Virus (HIV) Positive Patient Attributed to Sarcoidosis. Ocul Immunol Inflamm. 2006;14(5):309-11.
577. Kafkala C, Choi J, Zafirakis P, Baltatzis S, Livir-Rallatos C, Rojas B, Foster CS. Mooren Ulcer: An Immunopathologic Study. Cornea. 2006 Jul;25(6):667-673.
578. Yilmaz T, Foster CS. Indocyanine Green Angiography. Contemporary Ophthalmology 2006; 5:19:1-8
579. Letko E, Bhol K, Anzaar F, Perez VL, Ahmed AR, Foster CS. Chronic Cicatrizing Conjunctivitis in a Patient With Epidermolysis Bullosa Acquisita.Arch Ophthalmol. 2006 Nov;124(11):1615-1618.
580. Papadaki TG, Zacharopoulos IP, Papaliodis G, Iaccheri B, Fiore T, Foster CS. Plasmapheresis for lupus retinal vasculitis. Arch Ophthalmol. 2006 Nov;124(11):1654-6.
581. Onal S, Foster CS, Ahmed AR. Efficacy of intravenous immunoglobulin treatment in refractory uveitis. Ocul Immunol Inflamm. 2006 Dec;14(6):367-74.
582. Choopong P, Nielsen PG, Perlman EM, Huang JJ, Dryja TP, Foster CS. Solitary myofibroma of the sclera. Cornea. 2007 Jan;26(1):114-6.
583. Teasley LA, Foster CS, Baltatzis S. Sclerokeratitis and Facial Skin Lesions: A Case Report of Pyoderma Gangrenosum and its Response to Dapsone Therapy. Cornea. 2007 Feb;26(2):215-219.
584. Cordero Coma M, Sobrin L, Onal S, Christen W, Foster CS. Intravitreal Bevacizumab for Treatment of Uveitic Macular Edema. Ophthalmology. 2007 Mar 14; [Epub ahead of print]
585. Yu EN, Paredes I, Foster CS. Surgery for hypotony in patients with juvenile idiopathic arthritis-associated uveitis. Ocul Immunol Inflamm. 2007 Jan-Feb;15(1):11-7.
586. Borboli S, Afshari NA, Watkins L, Foster CS. Presumed Oculoglandular Syndrome from Bartonella quintana. Ocul Immunol Inflamm. 2007 Jan-Feb;15(1):41-3.
587. Cervantes-Castaneda RA, Jawed N, Foster CS. Immunosuppressive Therapy for Noninfectious Uveitis. Retinal Physician 2007 March; 30-37
588. Gerstenblith AT, Thorne JE, Sobrin L, Do DV, Shah SM, Foster CS, Jabs DA, Nguyen QD. Punctate Inner Choroidopathy A Survey Analysis of 77 Persons.
Ophthalmology. 2007 Apr 13;
589. Teasley LA, Foster CS. Syphilis: an ophthalmologic update. Int Ophthalmol Clin. 2007 Spring;47(2):133-44.
590. Sobrin L, Foster CS. Cytomegalovirus retinitis after one decade of HAART. Int Ophthalmol Clin. 2007 Spring;47(2):155-64.
591. Tang J, Foster CS. Age-related Macular Degeneration. Contemporary Ophthalmology 2007;6:4:1-6
592. Coma MC, Yilmaz T, Foster CS. Tumour necrosis factor-alpha in conjunctivae affected by ocular cicatricial pemphigoid. Acta Ophthalmol Scand. 2007 May 4;
593. Simmons EP, Foster CS. Diabetic Retinopathy and Macular Edema. Contemporary Ophthalmology 2007;6:8:1-8
594. Teasley LA, Christen WG, Foster CS. Oral Non-Steroidal Anti-Inflammatory Agents in the Treatment of Chronic or Recurrent Non-Infectious Uveitis. Contemporary Ophthalmology 2007;6:11:1-8
595. Papadaki TG, Zacharopoulos IP, Pasquale LR, Christen WB, Netland PA, Foster CS. Long-term Results of Ahmed Glaucoma Valve Implantation for Uveitic Glaucoma.
Am J Ophthalmol. 2007 May 8;
596. Letko E, Gurcan HM, Papliodis GN, Christen W, Foster CS, Ahmed AR. Relative risk for cancer in mucous membrane pemphigoid associated with antibodies to the beta4 integrin subunit. Clin Exp Dermatol. 2007 May 25;
597. Gallagher MJ, Quinones K, Cervantes-Castaneda RA, Yilmaz T, Foster CS. Biologic Response Modifier Therapy for Refractory Childhood Uveitis. Br. J. Ophthalmol. 2007 91: p. 1341-1344
598. Cordero-Coma M, Anzaar F, Sobrin L, Foster CS. Systemic immunomodulatory therapy in severe dry eye secondary to inflammation. Ocular Immunology & Inflammation 2007;15:99-104.
599. Ahmed M, Niffenegger JH, Jakobiec FA, Ben-Arie-Weintrob Y, Gion N, Androudi S, Folberg R, Raizman MB, Margo CE, Smith ME, McLean IW, Caya JG, Foster CS. Diagnosis of limited ophthalmic wegener granulomatosis: distinctive pathologic features with ANCA test confirmation. Int Ophthalmol. 2007 Jun 23; [Epub ahead of print]
600. Gallagher MJ, Yilmaz T, Cervantes-Castaneda RA, Foster CS. The Characteristic Features of Optical Coherence Tomography in Posterior Uveitis. Br J Ophthalmol. 2007 Jun 25; [Epub ahead of print]
601. Sobrin L, Kim EC, Christen W, Papadaki T, Letko E, Foster CS. Infliximab therapy for the treatment of refractory ocular inflammatory disease. Arch Ophthalmol. 2007 Jul;125(7):895-900.
602. Wick MR, Foucar E, Allen PW, Alves VA, Bjornsson J, Bosman F, Churg AW, Drut R, Foster CS, Hauptmann S, Hytiroglou P, Kuo TT, Matsubara O, Nappi O, Pervez S, Rosai J, Sasano H, Vielh P, Zelger B. Medicolegal liability in pathology: an international perspective. Semin Diagn Pathol. 2007 May;24(2):65-76.
603. Topalkara A, Ben-Arie-Weintrob Y, Ferry JA, Foster CS. Conjunctival Marginal Zone B-cell Lymphoma (MALT Lymphoma) with Amyloid and Relapse in the Stomach.
Ocul Immunol Inflamm. 2007 Jul-Aug;15(4):347-50.
604. Cordero-Coma M, Anzaar F, Yilmaz T, Foster CS. Herpetic retinitis.
Herpes. 2007 Jun;14(1):4-10.
605. Sobrin L, Kump LI, Foster CS. Intravitreal clindamycin for toxoplasmic retinochoroiditis.
Retina. 2007 Sep;27(7):952-7.
606. Foster CS, Korenfeld M. New potent difluprednate advances through Phase III Studies. Ophthalmology Times 2007 Sep 15; 36-37
607. Durrani K, Ahmed M, Foster CS. Adamantiades-Behcet Disease: Diagnosis and Current Concepts in Management of Ocular Manifestations.Compr Ophthalmol Update. 2007;8(4):225-233.
608. Levinson RD, Foster CS, Jaffe GJ. Management of chronic uveitis. Focal Points; December 2007, Volume 25, Number 11
609. Magee CC, Coggins MP, Foster CS, Muse VV, Colvin RB. Case records of the Massachusetts General Hospital. Case 2-2008. A 38-year-old woman with postpartum visual loss, shortness of breath, and renal failure.N Engl J Med. 2008 Jan 17;358(3):275-89.
610. Sayegh RR, Ang LP, Foster CS, Dohlman CH. The Boston Keratoprosthesis in Stevens-Johnson Syndrome. Am J Ophthalmol. 2008 Jan 18; [Epub ahead of print]
611. Sobrin L, Christen W, Foster CS. Mycophenolate Mofetil after Methotrexate Failure or Intolerance in the Treatment of Scleritis and Uveitis.Ophthalmology. 2008 Jan 24; [Epub ahead of print]
612. Kempen JH, Daniel E, Gangaputra S, et.al. for the Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Research Group. Methods for Identifying Long-term Adverse Effects of Treatment in Patients with Eye Diseases: The Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study. Ophthalmic Epidemiology. 2008 Jan-Feb;15(1):47-55.

613. Huynh N, Cervantes-Castaneda RA, Bhat P, Gallagher MJ, Foster CS. Biologic response modifier therapy for psoriatic ocular inflammatory disease. Ocul Immunol Inflamm. 2008 May-Jun;16(3):89-93.
614. Hinkle, DM, Foster CS. Autoimmune Inflammatory Vitreoretinal Disease: Pathogenesis, Progression, and Treatment. Retinal Physician; April 2008.
615. Gallagher MJ, Cervantes-Castaneda R, Bhat P, Foster CS. Primary Intra-ocular lymphoma: another great masquerader. European Journal of Ophthalmology. 2008; Jul-Aug;18(4): 567-71.

616. Hinkle DM, Foster CS. Tubulointerstitial nephritis and uveitis syndrome. Int Ophth Clin. 2008 Spring;48(2):9-13.

617. Callanan, DG, Jaffe, GJ, Martin, DF, Pearson, PA, Comstock, TL. Treatment of Posterior Uveitis With a Fluocinolone Acetonide Implant. Arch ophthalmol. 2008 Sep; 126(9): 1191-1201.
618. Doctor, P, Bhat P, Foster, CS. Subconjunctival bevacizumab for corneal neovascularization. Cornea Journal. 2008 Oct; 27(9): 992-995.
619. Choopong, P, Tauber, J, Foster, CS. Wegener Granulomatosis. Contemporary Ophthalmology. 2008 Oct 15; 7(19): 1-7.
620. Acevedo S, Quinones K, Rao V, Cervantes-Castaneda, RA, Foster CS. Cataract Surgery in children with Juvenile Idiopathic Arthritis associated uveitis. Int Ophth Clin. 2008 Spring;48(2):1-7.

621. Sobrin L, Huang JJ, Christen W, Kafkala C, Choopong C, Foster CS. Daclizumab for Treatment of Birdshot Chorioretinopathy. Arch Ophthalmol. 2008;126(2):186-191.

622. Rao V, Gallagher MJ, Bhat P, Foster CS. Sensorineural Hearing Loss In A Patient With HLA-B27 Sclero-Uveitis. Brit Journal Ophthalmol 2008; 92;3.

623. Anzaar F, Gallagher MJ, Bhat P, Arif M, Farooqui M, Foster CS. Use of Systemic T-cell Lymphocyte Signal Transduction Inhibitors in the Treatment of Atopic Keratoconjunctivitis. Cornea 2008 Sep;27(8):884-8.

624. Kacmaz RO, Kempen JH, Newcomb C, et al.for the Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Group. Ocular Inflammation in Behect’s Disease: Incidence of Ocular Complications and Loss of Visual Acuity. American Journal of Ophthalmology. 2008 Dec;146(6):828-36.

625. Doctor P, Bhat P, Yilmaz T, Foster, CS. Subconjunctival bevacizumab for corneal neovascularization. Cornea 2008 Oct;27(9):992-5.

626. Doctor P, Bhat P, Foster CS. Peripheral Ulcerative Keratitis. Contemporary Ophthalmology. 2008 Dec 15; 7(23): 1-7.

627. Iaccheri B, Fiore T, Papadaki T, Androudi S, Janjua S, Bahaila I, Foster CS. Adverse drug reactions to treatments for ocular toxoplasmosis: A retrospective chart review. Clinical Therapeutics. 2008 Nov;30(11):2069-74.

628. Fortuna E, Cervantes-Castañeda R, Bhat, P, Doctor P, Foster CS. Flare-up rates with Bimatoprost Therapy in Uveitic Glaucoma. American Journal of Ophthalmology. 2008 Dec;146(6):876-82.

629. Kempen JH, Gangaputra S, Daniel E, et.al. Long-term malignancy among patients treated with immunosuprressive agents for ocular inflammation: a critical assessment of the evidence. American Journal of Ophthalmology. 2008 Dec; 146(6):802-12.e1.

630. Iaccheri B, Fiore T, Papadaki T, Androudi S, Janjua S, Bhaila I, Foster CS. Adverse drug reactions to treatments for ocular toxoplasmosis: a retrospective chart review. Clinical Therapeutics. 2008 Nov;30(11):2069-74.

631. Bhat P, Castañeda-Cervantes R, Doctor P, Foster CS. Intravenous daclizumab for recalcitrant ocular inflammatory disease. 2009 Feb 6.

632. Hamam R, Bhat P, Foster CS. Conjunctival/Corneal Intraepithelial Neoplasia. International Ophthalmology Clinics. 2009 JAN; 49(1): 63-70.

TOP

In Press

1. Stavrou P, Yu E, Baltatzis S, Gion N, Zein G, Foster CS. Visual Outcomes after Cataract Surgery in Patients with Severe, Persistant Scleritis. Middle East Journal of Ophthalmology

2. Yilmaz T, Gallagher M, Foster CS. Systemic lupus choroidopathy. Ophthalmic Photography

3. Iaccheri B, Papadaki T, Ko C, Fiore T, Zacharopoulos, Thadani S, Christen S, Foster CS. Serum soluble interleukin-2 receptor levels do not correlate with an associated systemic disease in patients with uveitis. ACTA Ophthalmologica.

4. Cervantes-Castañeda R, Bhat P, Fortuna E, Acevedo, Foster CS. Induction of Durable Remission in Ocular Inflammatory Diseases. European Journal of Ophthalmology.

5. Gallagher MJ, Yilmaz T, Foster CS. Vogt-Koyanagi-Harada Syndrome associated with bilateral serous macular detachments responsive to immunomodulatory therapy. Ophthalmic Surgery Lasers & Imaging.

6. Fiore T, Iaccheri B, Androudi S, Anzaar F, D’ Amico DJ, Foster CS. Acute posterior multifocal placoid pigmentepitheliopathy: outcome and visual prognosis. Retina Journal.

7. Doctor P, Bhat P, Foster CS. Intravitreal Bevacizumab for Uveitic Choroidal Neovascularization. Ocular Immunology and Inflammation.

8. Kempen JH, Gangaputra S, Newcomb C, et.al. for the Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Research Group. Methodtrexate for ocular inflammatory diseasies: The Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study. Ophthalmology.

9. Durrani K, Foster CS. Management of Uveitis: Current concepts and modalitites. Contemporary Ophthalmology.

10. Cervantes-Castañeda R, Giuliari GP, Yilmaz T, McDonnell RE, Foster CS. Intravitreal Bevacizumab in Refractory Uveitic Macular Oedema: One year follow up. European Journal of Ophthalmology.

11. Quiñones K, Cervantes-Castañeda R, Hynes AY, Daoud YJ, Foster CS. Outcomes of Cataract Surgery in Children with Chronic Uveitis. Journal of Cataract and Refractive Surgery.

Book Chapters
1. Foster CS, Allansmith MR. 1979. Lack of Blood Group Antigen A on Human Corneal Endothelium. Immunology and Immunopathology of the Eye. (Eds. Silverstein, A.M., O’Connor, G.R.) Masson & Cie, New York. pp. 151-156.
2. Foster CS. 1982. Preocular Tear Film Abnormalities: Diagnosis and Treatment. Current Management in Ophthalmology. (Eds. Koch, D.D., Parke, DW., Paton, D.) Churchill-Livingstone, Inc., NY. pp. 25-55.
3. Foster CS. 1983. Corneal Manifestations of Neurologic Diseases. The Cornea. (Eds. Thoft, R.A., Smolin, G.) Little, Brown and Co., Boston, MA. pp. 315-328.
4. Foster CS. 1983. Ocular Manifestations of the Nonrheumatic Acquired Collagen Vascular Diseases. The Cornea. (Eds. Thoft, R.A., Smolin, G.) Little, Brown and Co., Boston, MA. pp. 264-284.
5. Foster CS. 1984. Wegener’s Granulomatosis. Current Ocular Therapy, 2nd ed. (Eds. Fraunfelder FT and Roy FH) W.B. Saunders Company, Philadelphia, PA. pp. 118-119.
6. Fujikawa LS, Bhan AK, Foster CS. 1984. T-Cell Subsets and Langerhans’ Cells in Conjunctival Lesions. Advances in Immunology and Immunopathology of the Eye (Ed. O’Connor, G.R.), Masson, New York. Chapter 13, pp. 43-47.
7. Foster CS, Wetzig R, Knipe D, Greene MI. 1985. Genetic Influence From Chromosome 12 on Murine Susceptibility to Herpes Simplex Keratitis. Herpetic Eye Diseases. (Eds. Maudgal PC and Missotten L) Dr. W. Junk. Pub., Dordrecht. pp. 67-76.
8. Foster CS. 1985. Systemic Immune Responses After Ocular Antigen Encounter. Herpetic Eye Diseases. (Eds. Maudgal PC and Missotten L) Dr. W. Junk Pub., Dordrecht. pp. 77-89.
9. Foster CS. 1986. Keratitis. Current Therapy in Infectious Disease. B.C. Decker, Inc., Philadelphia, PA. pp. 281-287.
10. Foster CS, Sonntag HG. 1986. Essentials of Microbiology in Uveitis. Uveitis: Pathophysiology and Therapy. (Eds. Kraus-MacKiw, E. and O’Connor, G.R.) Thieme Medical Publishers, Inc., NY. pp. 29-46.
11. Foster CS. 1987. Nonsteroidal Anti-inflammatory and Immunosuppressive Agents. Clinical Ophthalmic Pharmacology. (Eds. Lambert DW, Potter DE) Little, Brown, Inc., Boston, MA. pp. 173-192.
12. Foster CS, Mark DB. 1987. Corneoscleral Lacerations and Anterior Segment Reconstruction. Atlas of Ophthalmic Surgery Vol. II. (Eds. Heilmann K and Paton D.) Thieme Medical Publishers, Inc., New York. Chapter 5, pp. 1-48.
13. Foster CS. 1988. Basic Ocular Immunology. The Cornea. (Eds. Kaufman, H.E., et al.) Churchill Livingston, NY. pp. 85-122.
14. Foster CS, Jacobs DS, Reddy CV. 1992. Ocular Manifestations of Acquired Connective Tissue Disorders. Collagen Pathobiochemistry. Vol. 5. (Ed. Kang, AH., & J.B. Lippincott Co. Philadelphia). 161-180.
15. Foster CS. 1992. Fungal Keratitis. Infectious Disease Clinics of North America: Ocular Infections. (Eds. Michael Barza, M.D. and Jules Baum) 6:4;851-857.
16. Foster CS. 1990. Erythema Multiforme. The Eye in Systemic Disease. (eds. Gold DH, Weingeist TA). pp. 637-8.
17. Neves RA, Foster CS. 1994. Doenças Cicatriciais da Conjuntiva. Cornea. (eds. Belfort R and Kara-José N). Editora Roca, Sáo Paulo, Brazil.
18. Foster CS. 1994. Chapter 70: Syphilis. Duane’s Foundations of Clinical Ophthalmology. (Tasman W and Jaeger EA, eds.) J.B. Lippincott Co., Philadelphia. 2:1-8.
19. Sainz de la Maza M, Foster CS. 1994. Chapter 23: Sclera. Duane’s Foundations of Clinical Ophthalmology (Tasman W Jaeger EA, eds.) J.B. Lippincott. 1:1-17.
20. Ayliffe W, Foster CS. 1995. Immune-Mediated Diseases of the Eye. Surgical Management in External Diseases of the Eye. (Stenson S, Ed) Igaku-Shoin, New York. pp. 239-302.
21. Foster CS. 1995. Chapter 27: The Eye in Skin and Mucous Membrane Disorders. Duane’s Foundations of Clinical Ophthalmology. (Tasman W and Jaeger EA, eds.) 5:1-41.
22. Tauber J, Foster CS. 1995. Cicatricial Pemphigoid. Eye and Skin Disease (Mannis MJ, Macsai MS and Huntley AC, Eds.). Raven Press. pp. 261-271.
23. Brody J, Foster CS. 1996. Vernal Conjunctivitis. Ocular Infection and Immunity. (Eds. Jay S. Pepose, Gary N. Holland and Kirk W. Wilhelmus). pp. 367-375.
24. Haimovici R, Foster CS. 1996. Sarcoidosis. Ocular Infection and Immunity. (Eds. Jay S. Pepose, Gary N. Holland and Kirk R. Wilhelmus). pp. 754-776.
25. Foster CS. 1996. Immunology of Infections. Infections of the Eye, 2nd Edition. (Tabbara KF and Hyndiuk RA, eds.) Little, Brown and Co. pp. 13-34.
26. Foster CS, Power WJ. 1996. Basic Ocular Immunology. In: Seminars in Ophthalmology, Uveitis and Ocular Inflammation; ( Friberg TR, Wu HK, eds.) W.B. Saunders, Philadelphia, PA. 11(1):3-9.
27. Foster CS. 1996. Autoimmune Uveitis. Current Therapy in Allergy, Immunology and Rheumatology, 5th Edition (Lichtenstein LM and Fauci AS, eds.). Mosby. Philadelphia, PA. 394-398.
28. Vitale A, Foster CS. 1997. The Pharmacology of Medical Therapy for Uveitis. Textbook of Ocular Pharmacology: Chapter 59: Corticosteroids. (Ed: Zimmerman TJ, Kooner KS, Shariv M, Fechtner RD) Lippincott Raven, Philadelphia p. 681-702.
29. Vitale A, Foster CS. 1997. The Pharmacology of Medical Therapy for Uveitis. Textbook of Ocular Pharmacology: Chapter 60: Mydriatic and Cycloplegic Agents. (Ed: Zimmerman TJ, Kooner KS, Shariv M, Fechtner RD) Lippincott Raven, Philadelphia p. 703-722.
30. Vitale A, Foster CS. 1997. The Pharmacology of Medical Therapy for Uveitis. Textbook of Ocular Pharmacology: Chapter 61: Nonsteroidal Anti-inflammatory Drugs. (Ed: Zimmerman TJ) Lippincott Raven, Philadelphia p. 681-702.
31. Vitale A, Foster CS. 1997. The Pharmacology of Medical Therapy for Uveitis. Textbook of Ocular Pharmacology: Chapter 62: Immunosuppressive Chemotherapy. (Ed: Zimmerman TJ, Kooner KS, Shariv M, Fechtner RD) Lippincott Raven p. 713-722.
32. Power WJ, Foster CS. 1998. Immunologic Diseases Affecting the Cornea. Corneal Diseases, Section IX, Chapter 18, 2nd ed. (Leibowitz HW, ed.).
33. Akpek EK, Merchant A, Pinar V, Foster CS. Ocular Rosacea: Patient Characteristics and Follow-up. 1998. Yearbook of Dermatology (Thiers BH and Lang PG, eds.)
34. Cockerham GC, Foster CS. 1999. Conjunctival Flaps. In: Brightbill FS, editor, Corneal Surgery: Theory, Technique and Tissue, 3rd edition. St. Louis: Mosby, Inc. pp. 135-141.
35. Rojas B, Foster CS. Cataract Surgery in Patients with Uveitis. 1999. The Oxford Textbook of Ophthalmology. (Easty D and Sparrow J, eds.) Oxford University Press.
36. Sainz de la Maza M, Foster CS. Scleritis and Episcleritis. 1999. The Oxford Textbook of Ophthalmology. (Easty D and Sparrow W, eds.) Oxford University Press.
37. Nguyen QD, Foster CS. 1999. Tectonic Procedures. In: Ophthalmic Surgery: Principles and Techniques, Volume 1: Anterior Segment Surgery. (Ed. D.M. Albert, M.D.) Oxford: Blackwell Science Ltd.
38. Streilein JW, Foster CS. 1999. Immunology – An Overview. Principles and Practice of Ophthalmology: Section II, Chapter 5, 2nd Edition. (Eds. Daniel M. Albert and Frederick A. Jakobiec). Philadelphia: WB Saunders Publishers. pp. 47-49.
39. Foster CS. 1999. A Cast of Thousands: The Cells of the Immune System. Principles and Practice of Ophthalmology: Section II, Chapter 6, 2nd Edition. (Eds. Daniel M. Albert and Frederick A. Jakobiec). Philadelphia: WB Saunders Publishers. pp. 50-60.
40. Foster CS. 1999. B Lymphocyte Responses. Principles and Practice of Ophthalmology:Section II, Chapter 8, 2nd Edition. (Eds. Daniel M. Albert and Frederick A. Jakobiec) Philadelphia: WB Saunders Publishers. pp. 66-73.
41. Foster CS, Streilein JW. 1999. Immune-Mediated Tissue Injury. Principles and Practice of Ophthalmology: Section II, Chapter 9, 2nd Edition. (Eds. Daniel M. Albert and Frederick A. Jakobiec) Philadelphia: WB Saunders Publishers. pp. 74-82.
42. Streilein JW, Foster CS. 1999. Regulation of Immune Responses. Principles and Practice of Ophthalmology Section II, Chapter 10, 2nd Edition (Eds. Daniel M. Albert, Frederick A. Jakobiec). Philadelphia: WB Saunders Publishers. pp. 83-94.
43. Foster CS. 1999. Pharmacologic Treatment of Immune Disorders. Principles and Practice of Ophthalmology: Section IV, Chapter 34, 2nd Edition.. (Eds. Daniel M. Albert and Frederick A. Jakobiec). Philadelphia: WB Saunders Publishers. pp. 346-353.
44. Foster CS. 1999. Immunologic Disorders of the Conjunctiva, Cornea and Sclera. Principles and Practices of Ophthalmology: Section VIII, Chapter 65, 2nd Edition. (Eds. Daniel M. Albert and Frederick A. Jakobiec). Philadelphia: WB Saunders Publishers. pp. 803-828.
45. Abad JC, Foster CS. 1999. Fungal Keratitis. Principles and Practice of Ophthalmology: Section VIII, Chapter 69, 2nd Edition. (Eds. Daniel M. Albert and Frederick A. Jakobiec). Philadelphia: WB Saunders Publishers. pp. 906-914
46. Merchant A, Foster CS. 1999. Lamellar Keratoplasty. Principles and Practice of Ophthalmology: Section VIII, Chapter 76, 2nd Edition. (Eds. Daniel M. Albert and Frederick A. Jakobiec). Philadelphia: WB Saunders Publishers. pp. 1020-1026.
47. Foster CS, O’Brien JM. 1999. Anterior Uveitis. Principles and Practice of Ophthalmology: Section IX, Chapter 87, 2nd Edition. (Eds. Daniel M. Albert and Frederick A. Jakobiec). Philadelphia: WB Saunders Publishers. pp. 1198-1216.
48. Hunter DG, Foster CS. 1999. Ocular Manifestations of Sarcoidosis. Principles and Practices of Ophthalmology: Section IX, Chapter 88, 2nd Edition. (Eds. Daniel M. Albert and Frederick A. Jakobiec). Philadelphia: WB Saunders Publishers. pp. 1217-1224.
49. Tamesis RR, Foster CS. 1999. Toxoplasmosis. Principles and Practice of Ophthalmology: Section XI, Chapter 152, 2nd Edition. (Eds. Daniel M. Albert and Frederick A. Jakobiec). Philadelphia: WB Saunders Publishers. pp. 2113-2118.
50. Foster CS, Tamesis RR. 1999. Ocular Syphilis. Principles and Practice of Ophthalmology: Section XI, Chapter 156, 2nd Edition. (Eds. Daniel M. Albert and Frederick A. Jakobiec). Philadelphia: WB Saunders Publishers. pp. 2159-2163.
51. Foster CS, Faris BM. 1999. Adamantiades-Behçet Disease . Principles and Practice of Ophthalmology: Chapter 164, 2nd Edition. (Eds. Daniel M. Albert and Frederick A. Jakobiec). Philadelphia: WB Saunders Publishers. pp. 2212-2220.
52. Foster CS, O’Brien JM. 1999. Childhood Arthritis and Anterior Uveitis. Principles and Practice of Ophthalmology: Section XVII, Chapter 325, 2nd Edition. (Eds. Daniel M. Albert and Frederick A. Jakobiec). Philadelphia: WB Saunders Publishers. pp. 4542-4554.
53. Dana MR, Reddy CV, Foster CS. 1999. Adult Rheumatoid Arthritis. Principles and Practice of Ophthalmology: Section XVII, Chapter 326, 2nd Edition. (Eds. Daniel M. Albert and Frederick A. Jakobiec). Philadelphia: WB Saunders Publishers. pp. 4555-4562.
54. Foster CS. 1999. Systemic Lupus Erythematosus. Principles and Practice of Ophthalmology: Section XVII, Chapter 327, 2nd Edition. (Eds. Daniel M. Albert and Frederick A. Jakobiec) Philadelphia: WB Saunders Publishers. pp. 4563-4569.
55. Foster CS. 1999. Giant Cell Arteritis. Principles and Practice of Ophthalmology: Section XVII, Chapter 328, 2nd Edition. (Eds. Daniel M. Albert and Frederick A. Jakobiec). Philadelphia: WB Saunders Publishers. pp. 4570-4577.
56. Foster CS, Yang J, 1999. Wegener’s Granulomatosis. Principles and Practice of Ophthalmology: Section XVII, Chapter 329, 2nd Edition. (Eds. Daniel M. Albert and Frederick A. Jakobiec). Philadelphia: WB Saunders Publishers. pp. 4578-4588.
57. Dana MR, Reddy CV, Foster CS. 1999. Scleroderma. Principles and Practice of Ophthalmology: Section XVII, Chapter 330, 2nd Edition. (Eds. Daniel M. Albert and Frederick A. Jakobiec). Philadelphia: WB Saunders Publishers. pp. 4589-4595.
58. Foster CS. Nguyen QD. 1999. Adamantiades-Behçet’s Disease. Principles and Practice of Ophthalmology: Section XVII, Chapter 331, 2nd Edition. (Eds. Daniel M. Albert and Frederick A. Jakobiec). Philadelphia: WB Saunders Publishers. pp. 4596-4605.
59. Hunter DG, Foster CS. 1999. Systemic Manifestations of Sarcoidosis. Principles and Practice of Ophthalmology: Section XVII, Chapter 332, 2nd Edition. (Eds. Daniel M. Albert and Frederick A. Jakobiec). Philadelphia: WB Saunders Publishers. pp. 4606-4615.
60. Baltatzis S and Foster CS. 1999. Ocular Candidiasis. Current Ocular Therapy 5 (Eds. Frederick T. Frauenfelder and F. Hampton Roy). Philadelphia: WB Saunders Company. pp. 53-55.
61. Harper S, Foster CS. 1999. Vitiligo. Current Ocular Therapy5 (Eds. Frederick T. Frauenfelder and F. Hampton Roy). Philadelphia: WB Saunders Company. pp. 156-158.
62. Nguyen QD, Foster CS. 2000. The Red Eye. Pediatric Ophthalmology. A Clinical Guide (Ed. Pamela F. Gallin). New York: Thieme. pp. 204-215.
63. Sippel KC, Foster CS. 2001. Five Pearls in Limbal Stem Cell Transplantation. 101 Pearls in Refractive, Cataract and Corneal Surgery (Eds. Melki SA, Azar DT). Thorofare, NJ: Slack Incorporated. pp. 111-120.
64. Sippel KC, Foster CS. 2001. Three Pearls in Amniotic Membrane Grafting. 101 Pearls in Refractive, Cataract and Corneal Surgery (Eds. Melki SA, Azar DT). Thorofare, NJ: Slack Incorporated. pp. 125-130.
65. Stavrou P, Foster CS. 2001. Intraocular Lens Surgery in Uveitis and Scleritis. Intraocular Lenses in Cataract and Refractive Surgery (Ed. Azar DT) Philadelphia: WB Saunders. pp 131-135.
66. Samson CM, Foster CS. 2001. Hypersensitivity: Antibody-Mediated Cytotoxic (Type II). Encyclopedia of Life Sciences. London: Macmillan Reference Limited.
67. Foster CS. 2002. Cicatricial Pemphigoid. The Ocular Adnexa. 827-833.
68. Sippel KC, Foster CS. 2006. Five Pearls in Limbal Stem Cell Transplantation. 101 Pearls in Refractive, Cataract and Corneal Surgery (Eds. Melki SA, Azar DT). Thorofare, NJ: Slack Incorporated. pp. 131-141.
69. Sippel KC, Foster CS. 2006. Three Pearls in Amniotic Membrane Grafting. 101 Pearls in Refractive, Cataract and Corneal Surgery (Eds. Melki SA, Azar DT). Thorofare, NJ: Slack Incorporated. pp. 145-153.

In Press
70. Streilein JW, Foster CS. 2008. Immunology – An Overview. Principles and Practice of Ophthalmology: Section II, Chapter 5, 3rd Edition. (Eds. Albert DM, Miller JW et al). Philadelphia: WB Saunders Publishers. pp..
71. Foster CS. 2008. A Cast of Thousands: The Cells of the Immune System. Principles and Practice of Ophthalmology: Section II, Chapter 6, 3rd Edition. (Eds. Albert DM, Miller JW et al). Philadelphia: WB Saunders Publishers. pp..
72. Foster CS, Anzaar F 2008. B Lymphocyte Responses. Principles and Practice of Ophthalmology:Section II, Chapter 8, 3rd Edition. (Albert DM, Miller JW et al) Philadelphia: WB Saunders Publishers. pp.
73. Foster CS, Streilein JW, Coma MC 2008. Immune-Mediated Tissue Injury. Principles and Practice of Ophthalmology: Section II, Chapter 9, 3rd Edition. (Albert DM, Miller JW et al) Philadelphia: WB Saunders Publishers. pp.
74. Streilein JW, Foster CS. 2008. Regulation of Immune Responses. Principles and Practice of Ophthalmology Section II, Chapter 10, 3rd Edition (Albert DM, Miller JW et al). Philadelphia: WB Saunders Publishers. pp.
75. Foster CS. 2008. Pharmacologic Treatment of Immune Disorders. Principles and Practice of Ophthalmology: Section IV, Chapter 34, 3rd Edition.. (Albert DM, Miller JW et al). Philadelphia: WB Saunders Publishers. pp.
76. Foster CS. 2008. Immunologic Disorders of the Conjunctiva, Cornea and Sclera. Principles and Practices of Ophthalmology: Section VIII, Chapter 65, 3rd Edition. (Albert DM, Miller JW et al). Philadelphia: WB Saunders Publishers. pp.
77. Kim EC, Hunter DG, Foster CS. 2008. Ocular Manifestations of Sarcoidosis. Principles and Practices of Ophthalmology: Section IX, Chapter 88, 3rd Edition. (Albert DM, Miller JW et al). Philadelphia: WB Saunders Publishers. pp.
78. Foster CS, Tamesis RR. 2008. Ocular Syphilis. Principles and Practice of Ophthalmology: Section XI, Chapter 156, 3rd Edition. (Albert DM, Miller JW et al). Philadelphia: WB Saunders Publishers. pp.
79. Foster CS, Klisovic DD. 2008. Adamantiades-Behçet Disease . Principles and Practice of Ophthalmology: Chapter 164, 3rd Edition. (Albert DM, Miller JW et al). Philadelphia: WB Saunders Publishers. pp.
80. Foster CS, O’Brien JM. 2008. Childhood Arthritis and Anterior Uveitis. Principles and Practice of Ophthalmology: Section XVII, Chapter 325, 3rd Edition. (Albert DM, Miller JW et al). Philadelphia: WB Saunders Publishers. pp.
81. Dana MR, Reddy CV, Foster CS. 2008. Adult Rheumatoid Arthritis. Principles and Practice of Ophthalmology: Section XVII, Chapter 326,3rd Edition. (Albert DM, Miller JW et al). Philadelphia: WB Saunders Publishers. pp.
82. Foster CS, Sobrin L 2008. Systemic Lupus Erythematosus. Principles and Practice of Ophthalmology: Section XVII, Chapter 327, 3rd Edition. (Albert DM, Miller JW et al) Philadelphia: WB Saunders Publishers. pp.
83. Foster CS, Yang J, 2008. Wegener’s Granulomatosis. Principles and Practice of Ophthalmology: Section XVII, Chapter 329, 3rd Edition. (Albert DM, Miller JW et al). Philadelphia: WB Saunders Publishers. pp.
84. Dana MR, Reddy CV, Foster CS. 2008. Scleroderma. Principles and Practice of Ophthalmology: Section XVII, Chapter 330, 3rd Edition. (Albert DM, Miller JW et al). Philadelphia: WB Saunders Publishers. pp.
85. Foster CS, Anzaar F. 2007. Extraocular Manifestations of Systemic Diseases. Pathobiology of Ocular Diseases. (Eds. Gordon K. Klintworth) pp
86. Onal S, Foster CS. Ocular Manifestations of systemic vasculitis. Vasculitis. (Eds. Ball & Bridges)
87. Quinones K, Foster CS. Ocular Allergy. Managing the Allergic Patient (Eds. Krouse)

88. JJ Huang, CS Foster. Systemic Immunosuppression in Rheumatologic Diseases. Retinal Vasculitis
89. Onal S, Foster CS. Ocular Manifestations of systemic vasculitis. Ball E, Bridges SL eds. Vasculitis. Oxford
90. Zoumalan C, Cockerham GC, Foster CS. Conjunctival Flaps and Amniotic membrane transplantation. Brightbill, McDonnell, McGhee, eds. Corneal Surgery, 4th edition

On-Line Publications

1. Roque MR, Foster CS. 2000. Vitreous Wick Syndrome. www.Emedicine.com: Ophthalmology – Vitreous.
2. Roque MR, Foster CS. 2000. Actinomycosis. www.Emedicine.com: Ophthalmology – Infectious Diseases.
3. Roque MR, Foster CS. 2000. Demodicosis. www.Emedicine.com: Ophtalmology – Infectious Diseases.
4. Roque MR, Foster CS. 2000. Syphilis, Ocular. www.Emedicine.com: Ophthalmology – Infectious Diseases.
5. Roque MR, Foster CS. 2000. Herpes Zoster. www.Emedicine.com: Ophthalmology – Infectious Diseases: Hemorrhagic.
6. Roque MR, Foster CS. 2000. Melanoma, Conjunctival. www.Emedicine.com: Ophthalmology – Conjunctiva.
7. Roque MR, Foster CS. 2000. Leiomyoma, Iris. www.Emedicine.com: Ophthalmology – Iris and Ciliary Body.
8. Roque MR, Foster CS. 2000. Chloroquine/Hydroxychloroquine Toxicity. www.Emedicine.com: Ophthalmolgy – Unclassified Disorders.
9. Waheed NK, Foster CS. 2000. Melanoma, Iris. www.Emedicine.com: Ophthalmology – Iris and Ciliary Body.
10. Letko E, Foster CS. 2000. Cictricial Pemphigoid. www.Emedicine.com: Ophthalmology – Conjunctiva.
11. Letko E, Foster CS. 2000. Stevens-Johnson Syndrome. www.Emedicine.com: Ophthalmology – Dermatological Diseases.
12. Samson CM, Foster CS. 2000. Retinopathy, Birdshot. www.Emedicine.com: Ophthalmoloby – Retina: Tractional.
13. Ekong A, Foster CS. 2000. Juvenile Rheumatoid Arthritis. www.Emedicine.com: Ophthalmology – Connective Tissue Disorders.
14. Ekong A, Foster CS. 2000. Dry Eye Syndrome. www.Emedicine.com: Ophthalmology – Lacrimal System.
15. Foster CS. 20001. New Cornea Research www.medscape.com – Ophthalmology: Association for Research in Vision and Ophthalmology 2001 Annual Meeting.
16. Foster CS. 2001. Cornea and External Disease Update. www.medscape.com – Ophthalmology: American Academy of Ophthalmology (AAO) 2001 Annual Meeting.
17. Foster CS, Rashid S. 2002. Juvenile Rheumatoid Arthritis. www.uveitissociety.org - Patient information.
18. Foster CS, Rashid S. 2002. Ocular Cicatricial Pemphigoid. www.uveitissociety.org - Patient information.
19. Foster CS. 20002. Advances in Uveitis. www.medscape.com – Ophthalmology: Association for Research in Vision and Ophthalmology 2002 Annual Meeting.
20. Foster CS. 2002. Advances in Cornea Research. www.medscape.com – Ophthalmology: American Academy of Ophthalmology 2002 Meeting.
21. Foster CS. 2003. The Cornea: New Biologic Research. www.medscape.com – Ophthalmology: Association for Research in Vision and Ophthalmology – Annual Meeting 2003.
22. Zein G, Foster CS. 2004. Management of cataract and Uveitis. www.eyetext.net.
23. Foster CS. 2006 Cataract Surgery and Uveitis. http://aaophp.aao.org/current_insight
24. Yu, EN, Yao L, Foster CS. 2006. Peripheral Ulcerative Keratitis. www.emedicine.com: Ophthalmology- Cornea
25. Letko E, Foster CS. 2006. Cictricial Pemphigoid. www.Emedicine.com: Ophthalmology – Conjunctiva.
26. Roque MR, Roque BL, Foster CS. 2006. Herpes Zoster. www.Emedicine.com: Ophthalmology – Infectious Diseases: Hemorrhagic.
27. Roque MR, Roque BL, Foster CS. 2006. Uveitis, Juvenile Idiopathic Arthritis. www.Emedicine.com: Ophthalmology – Iris & Ciliary Body.
28. Letko E, Foster CS. 2005. Stevens-Johnson Syndrome. www.Emedicine.com: Ophthalmology – Dermatological Diseases.
29. Roque MR, Roque BL, Foster CS. 2005. Syphilis, Ocular. www.Emedicine.com: Ophthalmology – Infectious Diseases.
30. Samson CM, Foster CS. 2005. Retinopathy, Birdshot. www.Emedicine.com: Ophthalmoloby – Retina: Tractional.
31. Roque MR, Foster CS. 2006. Chloroquine/Hydroxychloroquine Toxicity. www.Emedicine.com: Ophthalmolgy – Unclassified Disorders.
32. Foster CS, Arif M. 2006. Uveitis – Fuchs Heterochromic. www.emedicine.com: Ophthalmology – Iris and Ciliary body
33. Foster CS, Farooqui SZ. 2006. Central Sterile Corneal Ulceration. www.emedicine.com: Ophthalmology – Cornea
34. Foster CS, Farooqui SZ. 2006. Uveitis Classification. www.emedicine.com: Ophthalmology – Iris and Ciliary body
35. Anzaar F, Foster CS. 2006. Dry Eye Syndrome. www.emedicine.com Ophthalmology – Lacrimal System
36. Foster CS. 2007. Understanding Uveitis. www.medscape.com – Ophthalmology: Association for Research in Vision and Ophthalmology (ARVO) 2007 Annual Meeting.
37. Afshari NA, Afshari MA, Foster CS. 2008. Inflammatory Conditions of the Eye Associated with Rheumatic Diseases. www.springeronline.com Current Rheumatology Reports
38. Foster CS. 2008. Advances in the Diagnosis and Treatment of Uveitis. www.medscape.com – Ophthalmology: Association for Research in Vision and Ophthalmology (ARVO) 2008 Annual Meeting.
39. Roque MR, Roque BL, Foster CS. 2008. Herpes Zoster. www.emedicine.com eMedicine from WebMD.
40. Roque MR, Roque BL, Miserocchi E, Foster CS. 2008. Giant Cell Arteritis. /www.emedicine.com eMedicine from WebMD.
41. Roque MR, Roque BL, Miserocchi E, Foster CS. Uveitis, Juvenile Idiopathic Arthritis. 2008. www.emedicine.com eMedicine from WebM
42. Farooqui SZ, Foster CS, Sheppard JD. Uveitis, Classification. eMedicine from WebMD. Updated November 20, 2008. Available at: http://www.emedicine.com/oph/topic580.htm.

Books

1. Foster CS, et al (Ed). 1972. The Epidemiology of Venous Thrombosis, Milband Memorial Fund Quarterly, Volume 1, Part 2.

2. Foster CS, Sainz de la Maza, M. 1993. The Sclera. Springer-Verlag Publishers, New York.

3. Foster CS, Vitale A. 2001. Diagnosis and Treatment of Uveitis. WB Saunders, Philadelphia.

4. Foster CS, Azar DA, Dohlman CH. 2004. Smolin & Thoft’s The Cornea. Philadelphia: Lippincott, Williams & Wilkins

5. Pleyer U, Foster CS. 2007. Essentials In Ophthalmology: Uveitis & Immunological Disorders Springer Verlag, New York.

BIBLIOGRAPHY: See Publications Section for list with abstracts

TOP